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Abstract 
Adults with an opiate addiction have a higher rate of noncompliance with treatment, 
which limits its effectiveness and increases the burden of care for society. Effective 
treatment decreases emergency room visits, and overdoses. The tristate area of Kentucky, 
West Virginia, and Ohio has experienced increased opiate-related arrests and deaths. This 
study sought to measure the extent to which treatment type (medical treatment (MS) or 
faith-based component of service (FBS)) predicts compliance when measured by number 
of clean urine drug screens (UDSs) and number of kept pill count, over and above dual 
diagnosis, college education, and income. The on-site records of voluntary enrollees in an 
outpatient facility that used either MT alone or MT with FBS were reviewed.  
Spearman’s rho and multiple stepwise regression revealed that, with respect to clean 
UDSs or kept pill count, the association between dual diagnosis and college education 
was not found to be statistically significant.  Rather, income explained about 5% of the 
variance in clean UDSs with a significant f change of .019, while type of treatment did 
not significantly impact clean UDSs. Dual diagnosis, income, and college education were 
not found to be significantly associated with the number of kept pill count. According to 
this study, type of treatment did not significantly impact compliance in the tristate area of 
Appalachia as measured by clean UDSs or kept pill count. Since MT and FBS are so 
similar in their relationship to compliance, attendance and participation in treatment may 
be areas for future study.  
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Chapter 1: Introduction to the Study  
Background 
Globally, more than 205 million people illicitly use opiates while 25 million 
suffer from dependence issues, making illicit opiate use a problem  impacting  health, 
socioeconomic, and security perspectives (World Health Organization [WHO], 2008).  
 In the United States, more than 52 million people above the age of 12 reported 
using opiates for nonmedical purposes (National Survey on Drug Use and Health 
[NSDUH], 2008). 6.2 million people currently use opiates for nonmedical purposes on a 
regular basis. More than one million people in the United States suffer with an opiate 
addiction, while only 200,000 attend programs offering medication assisted treatment 
(McCance-Katz, 2004). Opiate use produces undesirable consequences to society and the 
individual including increased relapse, an increase in communicable diseases, an increase 
in hospital emergency room presentation, and overdoses (Smith-Rohrberg et al., 2004). In 
2009 there were a reported 1.2 million drug-related emergency room visits (SAMHSA, 
2009) compared to 125,508 in 1995-1996 (Patel & Zed, 2002). In 2009, the number of 
individuals seeking treatment for addiction to painkillers increased by 400% from 1998 to 
2008 and opioid painkillers was the leading cause of death even exceeding motor vehicle 
deaths in the United States (SAMSHA, 2009).  
Appalachian society has been dramatically impacted by opiate abuse (Shannon, 
2011; Zhang et al., 2008). In Kentucky, arrests and deaths associated with opiate use have 
skyrocketed. In 2008, there were 32 heroin related arrests (The Kentucky Office of Drug 
Control, 2012) compared to 676 arrests in 2012 for the Louisville Metropolitan Area with 
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50 deaths linked to heroin overdose (Musgrave, 2012). There were 921 cases involving 
opiates and appearing in circuit courts  for 2012 compared with only 456 in 2011 
(Kentucky’s Administrative Office of the Courts, 2012) while district courts also noted 
an increase in cases with 679 in 2011and 1,784 in 2012. (Kentucky Administrative Office 
of the Courts, 2012).  
The notoriety regarding opiate use and misuse in Appalachia was brought to 
public attention through numerous media reports describing the nonmedical use of 
opiates in Appalachia and its link to Appalachian culture and economics (Lipman, 2003; 
Zancy, 2003). A report issued in October 2013 from the Trust for America’s Health 
(2013) in conjunction with the Robert Wood Johnson Foundation, listed West Virginia as 
having the highest rate of drug overdose deaths in the United States at 28.9 per 
100,000—a 605% increase from 1999. The same report listed Kentucky as third in the 
nation, at 23.6 per 100,000, and Ohio as twelfth at 16.1 per 100,000. 
Noncompliance limits treatment effectiveness and may increase the burden of 
care for society (Weiss, 2004). Individuals having substance use disorders are at a higher 
risk of noncompliance with prescribed treatment and noncompliance considerably 
jeopardizes treatment efficacy (Weiss, 2004).  Effective opioid treatment would decrease 
relapse, decrease communicable disease, hospital emergency room visits, and overdoses 
(Smith-Rohrberg, et al, 2004). Increased arrests and death associated with opiate 
addiction have dramatically impacted Appalachia, including the tristate area of Kentucky, 
West Virginia, and Ohio (Cicero, Inciardi, & Muñoz, 2005; Havens et al., 2007; Zhang, 
Omfamte, Meit, & English, 2008).  
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The effectiveness of MT for opiate addiction has been documented by Fiellin et 
al. (2008) and by Minozzi, Davoli, and Vecchi (2011). Augmenting MT by integrating a 
FBS component has also been advocated (Ison et al., 2006; Neff, Shorkey & Windsor, 
2006; Thomas & Lo, 2010).    
Purpose Statement 
The purpose of this study was to determine which treatment approach—MT or 
FBS—produces better compliance among patients attending an opiate outpatient 
treatment center in Appalachia and to what extent do the variables of dual diagnosis, 
income, and college education predict compliance.  
Problem Statement 
Opioid medications are commonly prescribed for the treatment of pain. In 2001, 
only 181 million prescriptions were written (Meir & Marsh, 2013), but by 2006, more 
than 230 million prescriptions were written (Arria, Garnier-Dykstra, Caldeira, Vincent, & 
O’Grady, 2011), 2001 to 2012 showed an increase of 33% with more than 240.9 million 
prescriptions written in 2012 (Meir & Marsh, 2013).  
Opiate abuse and dependence has been defined as a chronic disease with a high 
rate of relapse (Compton, 2011; Kirchmayer et al., 2002), which has a negative impact on 
society (Day, Ison, & Strang, 2008). Addiction reduces life expectancy, and can cause 
direct adverse effects on others including family, co-workers, and members of the 
community (Carter, Hall, & Illes, 2012). Opiate addiction is chronic and life-long (Everly 
et al. (2011). There has been an increase in the occurrence of opiate-related misuse 
involving prescription medications, overdose, and legal charges against physicians 
   
4 
(Lewis, Combs, & Trafton, 2010). The use of opiates is a mounting concern: More than a 
million people suffer from dependence but there are only a limited number of treatment 
programs McCance-Katz (2004). To increase treatment efficacy, programs that 
emphasize compliance have been advocated (Gardner & Kosten, 2007). 
 More than 6 million people abuse or misuse prescription opiate medications in 
the treatment of pain (Kirsh & Fishman, 2011). Substance use was cited by Worley et al. 
(2005), as the number one health problem in the United States, impacting millions of 
American men, women, children and other family members each year.  The number of 
people dying from an overdose of opioids exceeded the number of people dying from 
vehicular accidents (The Substance Abuse and Mental Health Services Administration 
[SAMSHA], 2009).  Deaths from overdose of opioids is the second cause of 
unintentional death in the United States (Volkow & McLellan, 2011). The problem of 
death from opioid overdose continues to be a problem for society.  Deaths by opioid 
overdose increased from 4,030 in 1999 to 16,651 in 2010 (Meir & Marsh, 2013). 
Substance abuse effects the population from a financial perspective. In 2004, 
more than 19 million Americans reported existing drug use (Morgan & Crane, 2010). The 
financial medical treatment costs associated to substance use rose 5.9% annually from 
1992 thru 2002 and cost society $180.8 billion (Morgan & Crane, 2010).  Annually, the 
cost of opioid treatment exceeds $72 billion (The United States Department of Health and 
Human Services, 2012).   In 2012, insurance claims averaged $13,000 per person for lost 
time/wages for a claim not including opioids while the costs involved for a short-acting 
opioid were $39,000 and for a long-acting opioid were $117,000 (Meir & Marsh, 2013).  
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 From 1992 to 2002, hospital emergency room fatalities from overdose of 
hydrocodone and oxycodone also “increased by 170% and 450% respectively” (Boothby 
& Doering, 2007, p. 266). In 2010, there were 16,651 deaths due to opioid overdose (The 
United States Department of Health and Human Services, 2012). The rising impact on 
Americans of opioid treatment can be noted through the examination of emergency room 
(ER) admissions involving opioids by comparing the number of admissions from 2004 
with the number of admissions from 2011. In 2004 there were 299,498 admissions where 
opioid use was linked to the admitting diagnosis while in 2011 the numbers of ER visits 
associated with opioid use were 885,348 (Meir & Marsh, 2013).  
The Appalachian, tristate  area of Kentucky, West Virginia, and Ohio, has been 
dramatically impacted with increased arrests and death associated with opiate addiction 
(Cicero et al., 2005; Havens et al., 2007; & Zhang et al., 2008). The Kentucky Office of 
Drug Control (2012) reported 32 heroin related arrests in 2008 compared to 676 arrests in 
2012 for the Louisville Metropolitan Area with 50 deaths linked to heroin overdose. 
Kentucky’s Administrative Office of the Courts (2012) reported 921 cases appearing in 
circuit courts involving opiates for 2012 compared with only 456 in 2011. District courts 
also noted an increase in cases with 1,784 in 2012 and 679 in 2011. A report issued in 
October, 2013 from the Trust for America’s Health (2013) in conjunction with the Robert 
Wood Johnson Foundation, listed West Virginia as having the highest rate of drug 
overdose deaths at 28.9 per 100,000 individuals, this being a 605% increase from 1999. 
The same report also listed Kentucky as number three in the nation at 23.6 per 100,000 
and Ohio at number 12 at 16.1. 
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Untreated, undertreated, or noncompliant patients with opiate addiction may 
experience increased occurrences of physical illness, incidents of self-harm or injury, 
difficulties in daily functioning and social functioning, and sustained addiction (Fornili & 
Alemi, 2007). An increase in the effectiveness of treatment and client compliance may 
result in decreased health care utilization by this population. Increased compliance may 
also improve cost effectiveness when treating substance use (Morgan & Crane, 2010).  
Other problems exist in the treatment of substance use. Relapse and recidivism 
present as additional problems in opiate treatment. According to the Center for Substance 
Abuse Treatment (2010), relapse and recidivism are highest among those patients who 
are addicted to opiates because of failure to pass drug screenings or to comply with 
conditions of parole, typically leading to re-arrest and incarceration. Rowston (2002) 
related that 58% of illicit drug users have a history of illegal history. Even after a patient 
has obtained sobriety, the risk of relapse is substantial (Amato et al., (2011). Fiellin et al. 
(2008) reported only a 54% sobriety retention rate following three years of traditional 
outpatient based treatment while Caldiero, Parran, Adelman, and Piche (2006) identified 
only a 50% rate of sobriety following six weeks of traditional outpatient services.  
Predictors of relapse included lack of family support, lack of 12-step program 
involvement, recent history of polysubstance use, previous history of long-term opioid 
therapy, and failure to improve or diminish pain (Dunbar & Katz, 1996). Polysubstance 
use is defined as being the intake or administration of multiple substances by the 
individual (Barrett et al., 2006). Effective outpatient opioid treatment should include 
participation in a support program including group counseling (Compton, 2011). 
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Individuals self-detoxifying from opioids often relapse by resorting to alcohol and other 
prescribed medication to cope (Ison et al., 2006).  Individual and group psychotherapy 
co-implemented with medication assisted treatment improves treatment effectiveness 
(Fiellin et al., 2008).  
 The effectiveness of treating opiate addiction from a MT approach was 
documented by Fiellin et al. (2008) and Minozzi, Davoli, and Vecchi (2011) while the 
effectiveness of including a FBS component in the treatment of opiate addictions was 
documented by Ison et al. (2006), Neff et al. (2006), and Thomas and Lo (2010). The 
latter research showed that effective opiate treatment involves treating both the 
physical/psychological and spiritual issues. These were the only studies that I could 
identify supporting the integration of a FBS component in the treatment of opiate 
addiction and two of these studies were dated. None of the studies focused on the 
Appalachian region of Eastern Kentucky, Southern Ohio, and Western, West Virginia 
and none were specific for treatment involving Suboxone. Effective treatment is vital for 
opiate addiction and includes individual and group therapy and a variety of support 
services (Mattick & Hall, 1993; McLellan, Hagan, & Levine, 1998).  
Nature of the Study 
This study focused on the compliance of patients enrolled in an outpatient 
program for opioid addiction in the tristate area that I will refer to by the pseudonym, 
Eastern Appalachian Suboxone Treatment Center (EASTC). Patients participated in 
either medical treatment (MT) or a medical approach that incorporated a voluntary FBS. 
In this quantitative study, I carried out a secondary data analysis of electronic treatment 
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records from the previous year using multiple regression. Secondary, depersonalized data 
was downloaded from the client’s electronic record from the facility and was monitored 
by EASTC administrator. Recording of secondary data included attendance logs for 
group therapy, the presence (yes/no) of a dual diagnosis, the reported annual income, the 
presence (yes/no) of college education, number of clean UDSs, and number of kept pill 
count. Group attendance in the MT or FBS program was measured through the actual 
number of days attending. Compliance was defined as the number of clean UDSs and the 
number of kept pill count.  Clean UDSs were defined as not having any opiates found in 
the individuals’ urine after laboratory analysis. Kept pill count was defined as the number 
of times that the individual kept an appointment with the laboratory technician to have 
their Suboxone counted. This study investigated which treatment approach —MT or MT 
plus FBS—produces higher compliance among individuals attending an opiate outpatient 
treatment center.  
The EASTC is a private, for-profit agency employing one psychiatrist, a licensed 
clinical social worker, an independent laboratory, and two support staff. The total number 
of individuals served is around100. This treatment facility used Suboxone as the primary 
medication for the maintenance and treatment of opiate addiction (Diamant et al., 1998).  
Definitions 
This section defines often uses terms associated with this study.  
Abuse. Abuse is defined as any use of an illegal drug, or purposely self-inducing 
prescription medication for a non-prescribed purpose such as experiencing a rapid and 
dramatic change in an individual’s mood or consciousness (Kirsh & Fishman, 2011). 
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Abuse was defined as a “maladaptive pattern of substance use leading to clinically 
significant levels of impairment or distress” in one or more life area during the past 
twelve month period (American Psychiatric Association, DSM-IV-TR, 2000, p. 199). 
The American Psychiatric Association, Diagnostic and Statistical Manual of Mental 
Disorders, Fifth Edition (DSM-5, 2013) does not include the term abuse and no definition 
or description is given. 
Addiction. Addiction involves a chronicity and life-long persistence (Everly et al., 
2011). Addiction is defined as a “disease with both physical and psychological 
components” (McCance-Katz, 2004, p. 333).  
Adherence. Weiss (2004) defined adherence as the actions of the patient 
corresponding in compliance to the recommended treatment.  
Compliance. Compliance has been defined as “the extent to which a person’s 
behavior (in terms of taking medications, following diets, or executing lifestyle changes) 
coincides with medical or health advice” (Haynes, Taylor & Sackett, 1979, p.29). In this 
study, compliance was measured through agency electronic treatment records using 
TheraScribe, obtained from a previous one year time period measuring the number of 
group appointments attended, the number of clean UDSs, and the number of kept pill 
count which were kept.  
Dependence. Opiate dependence has been defined as a chronic disease with a high 
rate of relapse (Compton, 2011; Kirchmayer et al., 2002), recurrent use (Frances, First, & 
Pencus, 1995) and which have a negative impact on society (Day et al., 2008).  
Addiction. The DSM-IV-TR (2000) categorized substance disorders as either abuse or 
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dependence. The DSM-5 (2013, p. 484) combines abuse and dependence into a single 
diagnosis that includes two or more symptoms, ranging from mild to severe.  
The DSM-IV-TR defined dependence using the prior definition of abuse and 
included the qualifier of increased severity indicating problems in three or more life areas 
over the course of twelve months. The life areas included neglect of family, occupational 
responsibilities and duties, social contacts, or recreational activities in lieu of substance 
use. The major difference between abuse and dependence was severity (DSM-IV-TR, 
2000). The DSM-5 describes dependence in a manner that reflects the development of 
tolerance and withdrawal. Dependence is the first stage of addiction (DSM-5, 2013). 
Opiate dependence has been defined as a “serious, relapsing disease that has a 
deleterious impact on the health and well-being” (Benyamina, Reynaud, Blecha, & 
Karila, 2011, p. 1384) for those who are dependent. The dependent, non-dependents, and 
other community members may be impacted by opiate use through heath concerns such 
as contaminated needle use and cross infection, criminal activities, social isolation and 
stigma, and mortality. Clients attending the outpatient treatment program used in this 
study have received a diagnosis of opiate abuse or dependence from a licensed 
psychiatrist trained in the treatment of opiate addiction.  
 Suboxone. Suboxone is a combination medication composed of buprenorphine 
and naloxone and was first approved by the Food and Drug Administration (FDA) for 
opiate treatment in the United States in 2002 (Thomas et al., 2008). 
 Withdrawal. Common early symptoms of opiate withdrawal include: anxiety, 
nervousness or restlessness, feeling tense or keyed up, and difficulty sleeping (National 
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Institutes of Health, 2013). Some cold or flu like symptoms are common and include: 
nasal discharge, body or muscle pain or ache, and sweating. Advanced symptoms of 
withdrawal may include: nausea, vomiting, diarrhea, stomach pain, and dilated pupils. 
According to the standards of the outpatient treatment program, clients experiencing 
advanced symptoms of withdrawal were referred for inpatient treatment.   
 Control variables. Rubin and Babbie (1993) defined control variables as a 
“variable that is held constant in an attempt to further clarify the relationship between two 
other variables” (p. 696). The control variables (CV) used for this study were three: dual 
diagnosis, income, and college education.  
  Dual diagnosis. Dual diagnosis has been defined as the presence of a mental 
illness coexisting with an alcohol or drug problem in which the combination of the 
problem is larger than either separately (Patrick, 2003) and as a deteriorating condition 
that is both interrelating and chronic (Hoffman et al., 2003). In this study, dual diagnosis 
indicates the lack (no = 0) or presence (yes = 1) of both mental illness and substance 
abuse, as determined by the facility psychiatrist, listed in accordance to diagnostic criteria 
from the Diagnostic and statistical manual of mental disorders text revision (4th ed.), 
(DSM-IV-TR) and indicated on clinical intake for treatment services and filed in client’s 
chart using TheraScribe. The American Psychiatric Association in 2013 published a new 
revision of the Diagnostic and statistical manual of mental disorders (5th ed.), although 
the DSM-IV-TR was indicated due to data originating before the publication of the new 
revision.   
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 Income. Income was measured through reported annual income information 
obtained at the time of intake and electronically recorded in the clients chart by the social 
worker using TheraScribe.    
 College education. College education was measured through the self-reported 
response of the client answering no (o) or yes (1) to having attended college, results 
recorded in the clients chart by the social worker using TheraScribe.  
 Dependent variables. Variables have been defined by Rubin and Babbie (1993) as 
“a specific concept or theoretical construct” (p. 120) that is being investigated. A 
dependent variable is “a specific concept or theoretical construct” (Rubin & Babbie, 
1993) that is “being explained” (p. 120). A dependent variable is a variable that is 
hypothesized to vary depending on, or under the influence of, another variable” (Schutt, 
2009, p. 42). The dependent variables (DV) for this study included urine drug screens 
(UDSs) and kept pill count.  
 Urine drug screens. UDSs are defined as drug screens conducted at the facility by 
an independent laboratory representative to test for the presence of illicit substances, 
including opiates, marijuana, cocaine, amphetamines, benzodiazepines, PCP and 
methadone. All specimens were sent in a registered, securely sealed package from the 
independent laboratory representative working at EASTC, by FedEx to the parent 
laboratory where, after testing, a confirmatory report was issued to the facility 
psychiatrist and recorded in the clients’ electronic record. No UDSs were considered 
complete until the confirmatory report was received. UDSs were obtained at each group 
visit. UDSs were measured through the actual number of clean UDSs obtained within the 
   
13 
12 month period. A total of 24 possible clean UDSs exist for this study period. Similar 
measures have been used in UDSs for the treatment of opiates and alcohol (Goehl, 
Nunes, Quitkin, & Hilton, 1993; Johnson, Cloninger, Roache, Bordnick & Ruiz, 2000; 
Margolis, Hjelmstad, Bonci, & Fields, 2003; and Strain, Stitzer, Liebson, & Bigelow, 
1994). 
 Kept pill count. Kept pill count describes a measure of compliance. The client is 
asked to come to the treatment center and produce her medication for counting by the 
staff to determine if medication is being taken as prescribed. Kept pill count was 
measured through the number of actual kept pill count appointments within the 12-month 
period, having a total of 24 possible. Records of attendance to kept pill count were 
entered into the clients’ chart using TheraScribe.  
The independent variables (IV) for this study included MT and FBS. 
Medical treatment. MT, an independent variable, is treatment used in opiate 
addictions and includes the use of medication; urine drug screens (UDSs), kept pill count, 
and group participation and was measured through documentation of client’s 
participation in group counseling sessions, number of clean UDSs, and pill presentation 
by the LCSW taken from the individuals’ electronic record. Type of treatment was coded 
as 0 for MT.  
 Faith-based support. FBS, an independent variable, incorporates the MT 
components augmented with an emphasis on faith through the use of group therapy as a 
treatment component and was measured through documentation of client’s voluntary 
participation in group faith-based counseling sessions, number of clean UDSs, and kept 
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pill count presentation by the LCSW taken from the individuals’ electronic record. FBS 
was coded as 1 in the variable type of treatment. The FBS group differed from MT in that 
it emphasized additional elements of faith including prayer, meditation, supportive 
devotionals, and use of a 12-step foundation focusing on overcoming addictions through 
faith. Faith-based elements include prayer, active listening, support, and reading from 
religious text (Naranyanasamy & Owens, 2001).  
 Research Questions and Hypothesis 
This study was guided by the following research questions: 
RQ1: To what extent does type of treatment (MT or FBS) predict compliance, as 
measured by clean UDSs, over and above dual diagnosis, college education, and income?  
H0
1 = null hypothesis is R2change for Type of Treatment = 0. 
HA
1 = alternative hypothesis is R2change for Type of Treatment > 0. 
RQ2: To what extent does type of treatment (MT or FBS) predict compliance, as 
measured by kept pill count over and above dual diagnosis, college education, and 
income? 
H0
2= null hypothesis is R2change for Type of Treatment = 0.  
HA
2 = alternative hypothesis is R2change for Type of Treatment > 0. 
Data were obtained through on-site records review of compliance rates, taken 
from the clients’ existing agency electronic record, for a previous one year course of 
treatment and depersonalized by the researcher and monitored by EASTC administrator. 
Permission to conduct the study was obtained from the on-site director and Walden 
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University Internal Review Board Approval Number 10-06-14-0187970 and complied 
with Walden University practices and policies.  
Theoretical Basis 
This study was based on Maslow’s hierarchy of needs and the integrated dual 
disorder treatment model (IDDT) of Kola and Kruszynski (2010). 
The theoretical basis of FBS was Maslow’s hierarchy of needs (1943). Maslow’s 
model listed “considerable ramifications for the treatment of individuals with complex 
and multi-axial problems” (Best, Day, McCarthy, Darlington, & Pinchbeck, 2008, p. 306) 
and in this study referred to mental illness and substance use or dual diagnosis. This 
theory considered the interaction of multiple need factors on an individual including 
social and cultural aspects, psychological, and physiological. Maslow believed that 
everyone has the innate potential and desire for growth once the basic needs of the 
individual are met. Once the basic needs have been successfully met, the potential exists 
for ever higher growth, although growth may be inhibited by failure to attain those lower 
levels. Maslow called the highest level of growth self-actualization (McLeod, 2014). 
Self-actualization is a continual process which is developed through individual 
experiences and events in the persons’ life and which may vary with each individual. 
(McLeod, 2014).  Traditionally, individuals having a mental illness have been excluded 
from substance use treatment until they have the mental illness controlled (Center for 
Evidenced-Based Practices, 2011). Treating the mental illness need, the base need, prior 
to obtaining a higher level of treatment for substance use reflects the growth process of 
self-actualization suggested by Maslow.  The theoretical basis of MT was the integrated 
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dual disorder treatment model (IDDT) by Kola and Kruszynski (2010) which proposed 
treating existing mental illness and addictions concurrently.  
 IDDT is an evidenced-based practice that focuses on the dual diagnosis of the 
individual while combining treatment for both mental illness and substance use through 
the use of the same team of providers and at the same treatment location (Center for 
Evidence-Based Practices, 2011).  IDDT combines multiple treatment approaches 
including the use of medications, group and individual sessions, educational supports, 
and social interventions. Treatment members may include: psychiatrists, social workers, 
laboratory personnel, support staff, the individual and family members (Center for 
Evidence-Based Practice, 2011). According to Kola and Kruszynski (2010), “41% to 
65% of persons with a lifetime substance use disorder have a lifetime history” (p. 438) of 
mental illness. The basis for integrated dual-disorder treatment involved “cross-trained 
practitioners providing integrated, comprehensive services directed toward the two 
disorders simultaneously in the same venue with the goal of recovery from both 
illnesses” (Kola & Kruszynski, 2010, p. 439). 
Assumptions 
This study was based on the following 3 assumptions:  
(a) the information provided by the participant was valid and properly recorded in 
participants record,  
(b) compliance to treatment, specifically, attendance, UDSs, and kept pill count 
were collected and properly recorded in participants record 
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(c) both the MT and FBS were consistent and that FBS elements did not occur in 
MT.  
The assumptions for this study were necessary to the context of this study due to 
the nature of the study being drawn from archived data and from a prior year of service 
and that FBS elements did not occur in MT.  
Limitations   
           The limitations identified in this project included the time frame and review of 
archived records from the previous one year period. This might have limited the 
possibility to gaining access to a larger group of data.  
 The sample was drawn primarily from Eastern Kentucky, Southern Ohio, and 
Western West Virginia—a population with limited cultural diversity—having possible 
differences in background and beliefs regarding FBS versus people only using MT and 
from other geographical regions and thus may is not generalizable to the general 
population which is a threat to the external validity of the study (Frankfort-Nachmias & 
Nachmias, 2008). This might have limited the possibility to gaining access to a larger 
group of participants or participants from a more diversified geographical area.  
The data were obtained from EASTC’s archival electronic data. Using archived data  
assumed that the responses provided were truthful, honest, and recorded correctly at the 
facility.  
Scope and Delimitations 
      The study came at a time when the scope of practice is generating a lot of community 
awareness and attention from the media and local communities regarding the illicit use 
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and effect of opiates.  The use of an archival study from a prior year was seen as a 
strength ensuring confidentiality and that a maximum sample could be obtained. I would 
have liked to have used a larger sample from a longer period of time, and having a more 
diverse, geographic distribution.  
Significance of the Study 
This study helped fill a gap in the literature concerning the Appalachian area with 
regards to type of treatment and compliance in the treatment of opiates.  Other studies 
had addressed opiate treatment but few had compared type of treatment in Appalachia. 
Compliance in the treatment of opiate addiction may affect many different areas 
including: quality of life (Gardner & Kosten, 2007), cost effectiveness (Morgan & Crane, 
2010), and has been linked to reduced illegal activity and lowering high risk behaviors 
(McCance-Katz, 2004). From a financial perspective, Substance use costs society billions 
of dollars and thousands of lives annually (Day et al., 2008; Morgan & Crane, 2010; 
Kirsh & Fishman, 2011). Failure to maintain compliance with treatment impacts society 
through an increased number of HIV and Hepatitis C (HCV) cases, increased court 
expenses, unemployment, and family conflicts (Day et al., 2008). Noncompliance has 
been linked to an increased risk of HIV, Hepatitis B virus (HBV) and Hepatitis C 
(Gardner & Kosten, 2007). Chaar, Hanrahan, and Day (2011) and Webster et al. (2011) 
discussed the link of fatalities to opiate use. Increasing compliance in the treatment of 
opiate addictions may help reduce the negative impact on individuals and the burden of 
care on society. Findings of this study can be used to inform regarding effective future 
opiate treatment.  
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Summary 
 This chapter introduced the problematic issues of opiate addiction and compliance 
among patients attending an opiate outpatient treatment center in Appalachia. Illicit 
opiate use is problem not only globally (World Health Organization [WHO], 2008) but is 
a problem for the United States (National Survey on Drug Use and Health [NSDUH], 
2008) and  for Appalachia (Cicero, Inciardi, & Muñoz, 2005; Havens et al., 2007; Zhang, 
Omfamte, Meit, & English, 2008) while only a small percentage participate in treatment 
programs (McCancee-Katz, 2004). Noncompliance to treatment limits treatment 
effectiveness and increases the burden of care for society (Weiss, 2004). This study 
investigated which treatment approach —MT or MT plus FBS—produces higher 
compliance among individuals attending an opiate outpatient treatment center in 
Appalachia. The study came at a time when a lot of attention is being generated regarding 
the illicit use and effects of opiate use, increasing community awareness and attention 
from the media. This study helped fill a gap in the literature concerning the Appalachian 
area with regards to type of treatment and compliance in the treatment of opiates.   
Patients participated in either medical treatment (MT) or a medical approach that 
incorporated a voluntary FBS. In this quantitative study, I carried out a secondary data 
analysis of electronic treatment records from the previous year using multiple regression. 
The control variables included dual diagnosis, college education, and income. The 
dependent variables included UDSs and pill count.  The research questions asked to what 
extent does type of treatment (MT or FBS) predict compliance, as measured by clean 
UDSs and pill count, over and above dual diagnosis, college education, and income.  This 
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study was based on Maslow’s hierarchy of needs and the integrated dual disorder 
treatment model (IDDT) of Kola and Kruszynski (2010).  
Chapter 2 will discuss prior studies on noncompliance in treating opiate addiction 
in the outpatient medical and faith-based treatment settings. Chapter 3 will further 
explain quantitative multiple regression research. Chapter 4 will focus on the data 
collection and statistical test results using Spearman’s rho. Chapter 5 will review the key 
findings and interpretations, recommendations for future studies, and implications for 
positive social change.  
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Chapter 2: Literature Review  
Introduction  
The purpose of this study was to determine which treatment approach—MT or 
FBS—produces better compliance among patients attending an opiate outpatient 
treatment center in Appalachia and to what extent do the variables of dual diagnosis, 
income, and college education predict compliance. This chapter will review the 
theoretical foundations used for MT and FBS in the treatment of opiate addiction through 
use of a literature review. This chapter will also view the rationale applied when 
discussing the effectiveness of treatment when incorporating a faith-based regimen, and 
previous studies and the literature review related to MT and FBS. The literature on 
(IDDT) by Kola and Kruszynski (2010) and Maslow’s hierarchy of needs (1943) were 
examined with respect to opiate treatment. 
Search Strategy 
Data for this review were obtained by review of peer-reviewed journals, books, 
articles, printed and electronic books. Electronic databases included: EBSCOhost, 
PsychINFO, SocINDEX with Full Text, ERIC, PubMed, Google Scholar, Academic 
Search Premiere, MEDLINE were used, Websites included: Substance Abuse and Mental 
Health Services Administration (SAMHSA), National Institute on Drug Abuse (NIDA), 
National Institutes on Health (NIH), and the United States Veterans Administration 
Intranet. Search criteria included the following terms: faith, spirituality, religion, 
substance use, substance abuse, Suboxone, methadone, heroin, opiates, relapse, retention, 
compliance, and treatment outcome.  
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 Opiates Defined 
There are only two methods to obtain opiate medications; through prescription 
from a licensed certified provider or through illegal means (Compton & Volkow, 2005). 
Opiates are prescribed treatment for two primary reasons, acute pain with short term use 
and chronic pain with long-term use. Long-term use has been associated with addiction 
(Compton, 2011). The focus of this study was the compliance level in opiate treatment. 
Opiates are classified into either natural or synthetic substances medically used for the 
treatment and management of pain. Natural opiates include opium and a derivative called 
morphine. Heroin is a synthetic medication introduced in 1898 as a cough suppressant 
(SAMHSA, 2008). Other synthetic opioids include codeine, oxycodone (OxyContin), 
meperidine (Demerol), fentanyl (Sublimaze), and hydromorphone (Dilaudid).  
History of Opiate Use and Addiction as a Social Problem 
Opioid use is not a new issue and in fact, opiate use was legal in the United States 
during the nineteenth century. Opiates were commonly used in potions and liniments 
(Peele, 1985). However, the growth and amount of use has escalated over the years. 
Opiate use emerged as a serious problem during and following the Civil War (SAMHSA, 
2008), as opioids were prescribed for pain management. By 1900, over 300,000 people 
were addicted to opiates (SAMHSA, 2008).  
The Pure Food and Drug Act was enacted in 1906 as a first attempt to nationally 
limit opioids by requiring medications containing opioids to be labeled. In 1914, the 
Harrison Act attempted to regulate the manufacture, distribution, and prescription of 
opiates. The United States Supreme Court ruled in 1919 that addiction was not a disease 
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and limited the prescription of opiates by physicians. The first outpatient treatment 
centers for opiate addiction were founded in 1958 (SAMHSA, 2008).  
Opiate abuse remained a prevalent problem in the United States with 2.5 million 
new users over the age of 12 of illicit opiates in 2007 and 2.15 million using medically 
prescribed opiates (Weiss et al., 2010). There were a reported 628,000 new opioid abuse 
cases in 1990 (SAMHSA, 2009) but in 2001 the number of new abuse cases exceeded 2.4 
million (McCance-Katz, 2004). Opiate abuse “emerged as a major issue for the United 
States within the past decade and has worsened over the past few years” (Compton & 
Volkow, 2005, p. 103). Currently, more than six million people abuse or misuse 
prescription opioid medications for the treatment of pain (Kirsh & Fishman, 2011).  
Another way to measure the effect on society of opioid abuse and addiction is to 
view the financial cost. Failing to treat substance use results in expensive costs to society 
especially in the areas of incarceration and medical treatment (Davis et al., 2006). A 
quantitative study using an anonymous written survey was completed by 84 veterans 
attending a Veterans Administration opiate treatment program over a period of 60 days 
and found that 80% admitted to a recent criminal activity, the majority of them involving 
theft (Mays et al., 2005).  
From 1992 to 2002 hospital emergency room fatalities from overdose of 
hydrocodone and oxycodone “increased by 170% and 450% respectively” (Boothby & 
Doering, 2007, p. 266). Hospital emergency departments received an increasing number 
of requests from 2003 through 2007 for opiates in the treatment and management of pain 
(The Centers for Disease Control and Prevention, 2008). From 2004-2007 the number of 
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hospital emergency department visits related to opiate abuse almost quadrupled, 
increasing from 198,000 to 420,000 (Manchikanti, 2007). In 2009 there was a reported  
increase of 242.2%  in opiate or opiate-like substance overdoses seen in a hospital 
emergency room setting compared with 175,949 from 2004 (The Drug Abuse Warning 
Network [DAWN], 2009). The medical treatment costs associated to substance abuse 
rose 5.9% annually from 1992 thru 2002 and cost society $180.8 billion (Morgan & 
Crane, 2010). The medical health care cost to society for 2007 as $25.0 billion (Birnbaum 
et al., 2011, p. 657).  United States residents illegally use 80% of the international supply 
of opiates and 99% of hydrocodone (Manchikanti, 2007).  
Measures have been instituted to help curb the illicit and misuse of opiate 
medications. In September 2013, the Food and Drug Administration announced that 
extended release and long term pain medications containing opiates could only be 
prescribed for severe pain requiring 24 hour management and only after other pain 
medications had been unsuccessfully used (Preda, Liskow, Talavera, Harsch, & 
Dunayevich, 2013). The use and effectiveness of these extended and long-term 
medications will require future study.  
Costs to society are not merely measured in dollars but may also be measured by 
quality and quantity of life. Failure to maintain compliance with treatment impacts 
society through an increased number of HIV and Hepatitis C (HCV) cases, increased 
court expenses, unemployment, and family conflicts (Day et al., 2008). The cost of legal 
and police intervention due to substance use in the United States was $3.8 billion in 2007 
(Birnbaum et al., 2011, p. 657).  Noncompliance and illicit use have been linked to an 
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increased risk of HIV, hepatitis B virus (HBV) and hepatitis C (Gardner & Kosten, 2007; 
WHO, 2008). Opiate abuse costs Australian society in fatalities, the spread of infectious 
disease, violent drug motivated criminal activities, and family disturbance (Chaar et al., 
2011). Substance use costs society billions of dollars and thousands of lives annually 
(Day et al., 2008; Kirsh & Fishman, 2011; Morgan & Crane 2010, WHO, 2008). The 
total cost to society in 2007 for substance use was $55.7 billion (Birnbaum et al., 2011).  
Treatment Issues 
Prescription Medical Treatment  
Medications to treat opiate addiction include an agonist, antagonist, or a mixed 
agonist/antagonist (Nutt, 2010). An agonist is a substance such as oxycodone, heroin, or 
morphine that links to a brain cell receptor and elicits a response such as euphoric feeling. 
An antagonist links to a brain cell receptor but does not elicit a response, or only does so 
weakly. An antagonist prevents the opioid from attaching and prevents the euphoric 
feeling. Grant (2008) noted the effectiveness of antagonist medications in the treatment 
of heroin addiction through decreasing the urges to use through failing to achieve the 
desired feeling or outcome. A mixed agonist/antagonist is a substance that behaves like 
either an agonist or antagonist and depending on the dosage, can change its effect on the 
brain cell receptor. For every one dollar spent on medication assisted treatment for drug 
addiction saves between two and six dollars and has shown an impact in decreasing 
criminal behavior and re-incarceration (The National Institutes of Health, 2013).  
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Methadone Treatment 
Methadone maintenance treatment (MMT) is the primary treatment mode for 
opiate addiction (Seivewright, 2000). MMT requires the daily administration of 
methadone to help reduce symptoms of withdrawal (Ward, Hall, & Mattick, 1999). The 
client must report to a methadone treatment center once per day to receive administration 
of the medication. Compliance to this treatment regimen is usually monitored by 
treatment center staff. MMT may or may not include components of psychotherapy or 
psychoeducation. Psychoeducation is defined by Rowston (2002) as informing the client 
regarding medication treatment and management, the role of stress, identifying precursors 
and triggers of relapse, and the role of illicit drugs in exacerbating drug use.  
Methadone, developed in the 1930s, is an early medication approved by the FDA 
which is still used in the treatment of opiate addiction. This medication has been 
associated with a large amount of social stigma and is somewhat difficult to obtain 
(Urschel, 2009). Methadone is the most common method for opiate treatment 
(Drummond & Perryman, 2007) and is the primary type of treatment for opiate addiction 
in New York City (Spunt, 2003). Methadone must be taken daily to be effective, and 
treatment is usually continued over a period of several years. Methadone is most 
commonly prescribed in opiate treatment and that methadone serves as a replacement or 
substitutionary medication (Bond, Reed, Beavan & Strang, 2012). Methadone is used as a 
method for detoxification and for maintenance (Doran, 2008). Methadone treatment is 
cost effective, effective in reducing criminal activity associated with illegal drug use, and 
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in reducing HIV transmission from the use of dirty needles (Deck, Wiitala, & Laws, 
2006).  
Measuring methadone effectiveness. Gordon, Kinlock, Schwartz, and O’Grady 
(2008) conducted a three-group randomized controlled clinical trial from September 2003 
to June 2005 at a Baltimore pre-release prison on 211 male inmates having heroin 
dependence prior to incarceration. The researchers randomly assigned participants to one 
of three groups; (a) weekly counseling only with a limited referral for methadone 
treatment at time of release, (b) weekly counseling only while in prison and being 
transferred to a methadone treatment facility upon release, (c) weekly counseling and 
methadone treatment while in prison and follow up for counseling and methadone 
treatment upon release. Two hundred and one former prisoners were assessed at 6 months 
following release through use of UDSs, self-reported drug use, number of days 
reincarcerated during the six month follow-up period, and participation in the treatment 
program. The researchers found that participation in an opioid treatment program while 
incarcerated, involving counseling linked with methadone, and continued services 
following 6 months after release served to reduce self-reported heroin use, and heroin use 
as measured through UDS.  
Measuring methadone effectiveness with counseling. In contrast to the Gordon 
et al. (2008) study, Schwartz et al. (2011) conducted a randomized controlled 12 month 
study of 230 newly admitted adult methadone patients at two treatment facilities in 
Baltimore, MD. Patients were assessed using the Addiction Severity Index at admission 
in a blinded fashion prior to being assigned to a group. Patients were also assessed using 
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the Addiction Severity Index at 4 and 12 months in a non-blind manner. Patients were 
randomly assigned to one of three groups using block randomization consisting of 
placing patient identifying information in an envelope prior to group assignment. Patients 
were assigned to one of three groups. The first group focused on methadone treatment 
only. The second group focused on methadone treatment combined with counseling. The 
third group focused on methadone treatment combined with counseling received by a 
counselor with a reduced caseload. Retention rates were measured. UDS was also 
collected throughout the study. The researchers found that there were no significant 
differences in the retention rates of the patients or in the success of methadone or 
methadone with counseling. Easing of restrictions placed on methadone prescribers 
allowing for increased access to methadone and an increase in methadone only treatment 
programs (Spunt, 2003).  
Suboxone and Buprenorphine Treatment 
Suboxone is a combination medication containing buprenorphine and naloxone 
and was approved for the treatment of opiate addiction in 2000 by the FDA (Finch, 
Kamien, & Amass, 2007). Suboxone blocks the effects of opioids, decreases cravings, 
and suppresses major symptoms of withdrawal. If the client should have a relapse and use 
opiates, the client does not experience the feeling of high normally associated with opiate 
use. The typical course of treatment with Suboxone is 9 months to 2 years before tapering 
off (Finch et al., 2007).  
In 2002, buprenorphine was approved by the FDA for use in the treatment of 
opioid dependence. Buprenorphine is a partial antagonist medication, which in low 
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concentrations duplicates the effects of opioid agonists such as oxycodone or heroin. In 
higher concentrations, buprenorphine acts as an opiate antagonist. Even though 
methadone has been recognized since the early 1960’s as the leader in the treatment of 
opiate addictions, buprenorphine has proven to be more effective in maintenance 
(O’Connor, 2005). Methadone and buprenorphine were the two recommended long-term 
treatment options for opiate addiction (Finch et al., 2007).  
The effectiveness of buprenorphine and methadone was compared by Barnett, 
Zaric, and Brandeau (2001) using a systematic Medline literature search in an effort to 
identify peer reviewed, double blind, randomized clinical trials occurring before 1999 
which compared both medications. Retention in treatment was analyzed using a Cox 
proportional hazards regression. Urinalyses for opiates were studied with an analysis of 
variance. A meta-analysis was used to combine these results. The researchers found that 
lower dosages of buprenorphine had a 1.26 times higher drop- out rate (95% confidence 
level) than methadone. The researchers also found that higher dosages of buprenorphine 
were more effective than lower levels of methadone. The researchers concluded that 
further testing and analysis was necessary to determine significant results.  
Johnson, Jaffe, and Fudala (1992) studied a 17-week medication maintenance 
period, followed by an 8-week detoxification phase, and conducted a randomized, 
double-blind, parallel group study of 162 patients to test the short-term efficacy of 
buprenorphine. The authors compared the effect of 8 mg of buprenorphine with 
methadone 20 mg and methadone 60 mg per day over seventeen week maintenance and 
an eight week detoxification. The authors compared the retention and abstinence rate of 
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buprenorphine to methadone and found that throughout the maintenance phase retention 
rates using buprenorphine were 42% better than using methadone 20mg. Urine drug 
samples comparing buprenorphine and methadone showed retention and abstinence rates 
were significantly higher with buprenorphine. The authors found that buprenorphine was 
equally effective in the treatment of opiate addiction as methadone 60 mg.  
Measuring Suboxone effectiveness. Methadone and Suboxone share in their 
effectiveness of treatment for opiate addiction (Chapleo, 2003). The authors also noted 
that individuals using Suboxone had a lower incidence of becoming addicted to 
Suboxone. Suboxone was found to be safer when compared to the possible respiratory 
complications linked to methadone. Suboxone also offers an increased flexibility in 
administration of the medication which methadone does not. Suboxone may be self-
administered compared to methadone which must be taken daily and provided in a 
controlled clinical setting. 
Measuring Suboxone effectiveness with counseling. The effectiveness of 
incorporating counseling with Suboxone medication treatment was reported by Fiellin et 
al. (2006). The researchers in cooperation with the National Institute on Drug Abuse 
conducted a quantitative study involving 166 participants who were randomly assigned to 
one of three groups. Members of each group received medication management 
appointments with the prescriber including a brief counseling session with a nurse. Group 
one consisted of follow-up for once a week medication management. Group two 
consisted of three times per week medication management. Groups one and two had a 
total appointment time allotment of twenty minutes. Group three consisted of three times 
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per week medication management with a total appointment time of forty-five minutes to 
allow for additional counseling. Counseling consisted of discussions related to recent 
drug use, relapse, or support. All groups received UDSs monitoring. Drug use was 
monitored through weekly self-reports and UDSs. The researchers found that all three 
treatment types reduced self-reported opiate drug use frequency from 5.3 to 1.1 days and 
the UDSs measure did not show any significant difference. This suggests that although 
medication management is required in the successful treatment of opiate addiction, the 
frequency and amount of time spent in medication management is not significant.  
Naltrexone Treatment 
Another mediation approved by the FDA and used in the treatment of opiate 
addiction is the antagonist naltrexone. Naltrexone, in the form of an injectable medication 
called Vivitrol, was approved by the FDA in 2010 for the treatment of opioid addiction. 
Naltrexone was approved in 2006 for the treatment of alcohol dependence. Naltrexone 
acts on the brain cell receptors preventing a euphoric feeling. One possible problem in the 
use of naltrexone is that the client taking naltrexone may develop the misconception that 
since they are prevented from becoming high they are now free to use opiates freely and 
without consequence (Urschel, 2009). Naltrexone does not block cravings or desire for 
the opiate.  
  Measuring naltrexone effectiveness. Comer et al. (2006) conducted a 
multicenter, eight week, randomized, double-blind, placebo-controlled, parallel-group to 
rate the safety and efficiency of naltrexone. The researchers enlisted sixty adult heroin 
dependent users who were stratified by gender and years of heroin use and then 
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randomized to receive a placebo, a low dose, or a maintenance dose of naltrexone. All 
participants received counseling twice a week and UDSs. The researchers found a lower 
level of effectiveness in the placebo group when compared to the low dose naltrexone, 
and a lower level of effectiveness in the low dose naltrexone group when compared to the 
maintenance level dose.  
Naltrexone, administered orally, has been shown to have a low level of 
effectiveness based on high rates of relapse and noncompliance (Hyman et al. 2009). One 
possibility suggested for the high noncompliance and relapse rates is that naltrexone 
eliminates the subjective feelings and cravings associated with opiates without replacing 
the “powerful reinforcing effects of opioids” (Carroll et al., 2001, p. 755). Development 
is currently underway for a sustained release injection (Liberto & Fornili, 2013). With the 
introduction of a sustained release injection and the inclusion of counseling, hopes are for 
enhanced effectiveness.  
 Measuring naltrexone effectiveness with counseling. Behavioral therapies used 
in conjunction with nalterxone have shown a higher level of compliance and treatment 
retention (Carroll et al., 2001). Carroll et al. (2001) conducted a study using a 
randomization sample of 127 detoxified opioid dependent patients who were assigned to 
one of three groups over a twelve-week period. Group one received medication treatment 
three times a week. Group two received the same medication treatment with incentive 
vouchers and group three received the same medication treatment, incentive vouchers, 
had the support of a family member present, and received six family therapy sessions. 
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The researchers found that incentive vouchers helped to increase retention and decreased 
noncompliance and that family therapy sessions help to improve family functioning.  
    An Integrated Treatment Approach 
In the treatment of opiate addiction, medication maintenance is the principle 
method used (Fiellin, 2006). An integrated approach, combining medication 
management, monitoring, and counseling is recommended for effective treatment 
intervention. Coexisting mental illness and substance abuse disorders are best treated by 
programs, which are tailored for the needs of the individual (Drake, Mercer-McFadden, 
Muesser, McHugo, & Bond, 2001). McAuliffe and Ch’ien (1986) were early advocates of 
an integrated psychosocial approach to the treatment of opiates and Minkoff (1999) 
stressed the importance of an integrated approach in the treatment of substance use.  
The IDDT treatment model views every aspect in the life of the client as part of 
the recovery process. IDDT is an evidence-based, multidisciplinary practice technique 
that is recognized by the SAMHSA for the treatment of co-occurring mental health and 
substance abuse disorders (Drake et al., 2001).  Body, mind, and spirit are intertwined 
and that each requires integrated care (O’Brien, 2013). When working with dually 
diagnosed United States Armed Service veterans an integrated approach for treatment is 
recommended (Timko et al., 2003).  
Integrated treatment programs are not new. Treatment for dual diagnosis should 
be simultaneous and carefully synchronized to be effective (Minkoff, 1989). The 
National Institute of Mental Health (1989) and Teague et al. (1990) concurred that 
effective treatment of dual diagnosis focuses on integrating alcohol, drug, and mental 
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health treatments. The advantages of having a single location and coordination of 
services when dealing with clients involved in integrated treatment were discussed by 
Wingerson and Ries (1994).  Another advantage to an integrated approach is the ability to 
have clinicians who are cross-trained to service both mental health and substance use 
concerns (Drake et al., 1998). 
Integrated Treatment Approach Research 
The importance of an integrated treatment approach for addiction services was 
discussed by Grella, Gil-Rivas, and Cooper (2004). The authors viewed the findings from 
a UCLA dual diagnosis study of ten mental health and sixteen residential substance abuse 
programs to evaluate the outcomes of dually diagnosed clients. The authors presented 
areas of agreement and disagreement of administrators and staff from those treatment 
centers regarding the treatment of the dually diagnosed client. A factor analysis was 
conducted to determine common views regarding treatment. The extent of agreement was 
measured using a Likert scale. Scores were obtained and an analysis of variance using 
ANOVA for responses from four types of program directors; mental health 
administrators, mental health staff, substance use administrators, and substance use staff. 
The authors stated that a divergent mindset exists when comparing current treatment 
methods and an integrated approach would be best implemented at the administration 
level.  Markoff, Finkelstein, Kammerer, Kreiner, and Prost (2005) conducted a mixed 
methods study using snowball sampling, fixed list approach, and semi-structured 
interviews. The authors focused on three large human service agencies in three different 
communities in Eastern Massachusetts working with women experiencing domestic 
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violence and dual diagnosis. The authors found that an integrated treatment process 
involving cross training of professionals working in mental health, addictions, and 
domestic violence aided in treatment but that individual program mindsets and stigmas 
still posed a barrier. 
Crits-Christoph et al. (1999) conducted a study of four treatment centers with a 
total caseload of 487 patients. The patients were randomly assigned to one of four manual 
guided groups with varying approaches. Group number one used individual therapy with 
group therapy. Group number two used cognitive therapy and group therapy. Group 
number three included supportive-expressive therapy and group therapy and group four 
only used group therapy. The authors conducted thirty-six individual sessions and 
twenty-four group sessions over a period of 6 months. Clients were assessed each month, 
and during the ninth and twelfth months were given the Addiction Severity Index. The 
primary outcome measures were based on the Addiction Severity Index drug composite 
score and number of days self-reported cocaine use and UDS report. The authors found 
that all treatment modes provided improvements from the beginning of the study through 
completion but that treatment for opiate addiction was more effective when treated with 
an integrated approach incorporating medications and including both individual and 
group counseling.  
Of the people diagnosed as having a chronic history of substance abuse, “41% to 
65%” also have a chronic history of mental illness (Kola & Kruszynski, p. 438, 2010). 
Approximately 50% of individuals diagnosed with a chronic and severe mental illness 
also have a coexisting diagnosis of substance use (Drake et al., 2001). The effectiveness 
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of integrated treatment regarding alcohol use was advocated (Herman et al., 2000). The 
authors assigned clients to either an integrated approach treating both mental illness and 
substance use verses hospital treatment focused on treating mental illness and substance 
use separately. The authors conducted a randomized experimental, multilevel, nonlinear 
model of study over the course of 18 months with 429 randomized patients. Their 
findings showed that integrated treatment, treating mental illness and substance use 
concurrently reduced alcohol consumption among participants by 54%.  
Minkoff (2001), who assessed 246 admissions over a 21-month period for 
treatment of substance use and psychiatric illness, also supports an integrated approach 
for effective treatment based on the study findings. The main weaknesses of this study 
were the lack of a control group, no comparative data, and the primary use of clients 
reported subjective experiences. Hoffman, Abrantes, and Anton (2003) studied 126 
participants diagnosed with a dual diagnosis who were assessed at baseline, after 6 
months, and at three years to assess whether integrated treatment helped in the reduction 
of criminal activity and health care costs. The authors conducted semi-structured 
interviews and self-reporting to assess quality of life. The authors found that integrated 
treatment lowered illegal activity and health costs. Semi-structured interviews were 
initiated at 1 months, 6 months, and three years. Limitations to the study include the lack 
of a control group, lack of follow up for dropout, lack of independent evaluators, and the 
lessening of sample size over time.  
Davis et al. (2006) studied the effectiveness of integrative treatment using 
assertive community treatment (ACT) for individuals diagnosed as having a severe 
   
37 
mental illness and substance use. The authors used a retrospective study conducted at 24 
months of 38 participants diagnosed with a dual diagnosis. The authors conducted 
motivational interviewing and administered the Clinician Alcohol Use Scale (CAUS) and 
Clinician Drug Use Scale (CDUS). Random UDSs were also conducted. Their findings 
showed that an integrated treatment approach showed a reduction in alcohol consumption 
and a 71% retention rate.  
Kubek (2007) noted that IDDT is holistic in nature and considers the cultural 
background of the individual. Components of IDDT may include the use of individual, 
family, and/or group counseling for integrated mental illness and substance abuse/use, 
participation in self-help and support groups, pharmacological treatment, case 
management and outreach, supported employment and community 
integration/reintegration, and advocacy (SAMHSA, 2012).  
IDDT Summary 
IDDT seeks to treat both mental illness and substance abuse concurrently. The 
basis for integrated dual-disorder treatment involved “cross-trained practitioners 
providing integrated, comprehensive services directed toward the two disorders 
simultaneously in the same venue with the goal of recovery from both illnesses” (Kola & 
Kruszynski, 2010, p. 439). A high percentage of relapse exists for individuals suffering 
with a dual diagnosis and that separate, traditional means of treatment usually are 
ineffective (Drake et al., 2001). Using this treatment model among individuals diagnosed 
with a dual diagnosis would best address the individuals’ holistic needs. The theoretical 
framework for MT was based on the Integrated Treatment (IT) approach, which seeks to 
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provide treatment to the client for mental illness and substance use concurrently. Kola 
and Kruszynski (2010) introduced their model of the IDDT, which suggested treating 
existing mental illness and addictions concurrently.  
 In this study both the MT and FBS have a component of integration. Both the 
MT and FBS integrate medication management, urine drug screens, and group 
psychotherapy with the FBS differing in the additional services received. Prior to an 
integrated approach incorporating counseling for opiate treatment, clients received 
medication management, primarily through the use of methadone maintenance and 
monitoring through urine drug screens. 
 Faith-based Services (FBS) 
FBS focuses on the holistic needs of the individual in providing services designed 
to reduce instances of relapse.  Faith-based services have been defined as being centered 
upon the presence or absence of spiritual content within the parameters of the program 
(Neff et al., 2006). Religious faith plays an integral role in the development and 
substantiation of communal morals, integration to a positive support network, and 
establishing new values and goals (Durkheim, 1948). The concept of faith served to elicit 
edification and promote self- discipline and feelings of wellbeing within the individual 
(Alpert, 1961).  
The role of structured programs and faith in the treatment of substance use was 
discussed by White (1998). The idea of incorporating agape (love) in the treatment 
process and noted that this agape may be more readily found within faith-based programs 
was noted by Miller (2000). The use of a faith-based recovery model for substance use 
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treatment provides greater support and social strengthening for the individual (Moos, 
2006).  Faith-based care confirms a person’s sense of self-worth, helps to define a 
meaning and purpose for life, and helps to perpetuate emphatic feelings for others 
(Greasley, Chiu, & Gartland, 2001). Moreira-Almeida Neto, and, Koenig (2006) in a 
systematic review of 850 studies found that increased faith-based involvement was 
positively linked to lower substance use and less symptoms of depression among adults.  
Christian faith-based treatment programs have a long history of being the primary 
provider in the treatment of substance use (Hester, 2002). The Twelve-step program of 
Alcoholics Anonymous (AA), although not primarily defined as either Christian or 
religious, has a history derived from Christian faith-based treatment (Sellman, Baker, 
Adamson, & Geering, 2007) and an emphasis on spiritual tenets (AA World Services Inc. 
1981, 2001).  Faith-based programs serve a major role in the treatment of substance use 
(Cook, 2006; White & Whiters, 2005).  
FBS and Addiction.   FBS involvement serves as a safeguard against substance 
abuse and aids in achieving and maintaining continued sobriety (Stahler, Kirby, & 
Kerwin, 2007). Organizations incorporating a faith-based element to addiction treatment 
serve as protective elements when associated with alcohol and drug abuse (Ferguson, 
Dabir, Dortzbach, Dyrness and Spruijt-Metz, 2006). A holistic, integrated approach 
incorporating medication management, psychological and social interventions, and 
support systems when treating opiate addiction was recommended by WHO (2008). 
Involvement in a faith-based program has been shown to be effective for decreasing drug 
use (Gartner, Larson & Allen, 1991; Gorsuch, 1995; Kendler et al., 2003; Koenig and 
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McCullough, 2001; Piacentine, 2010). Hood (2011) advocated for the effectiveness of 
religious programs versus secular programs of treatment to substance abuse. Information 
regarding the effectiveness of faith-based programs in the treatment of substance abuse is 
inadequate and that further studies were necessary (Neff et al., 2005).  
The individual indicating a presence of faith in their lives has a lower percentage 
of substance use (Columbia University’s National Center on Addictions and Substance 
Abuse [CASA], 2001). Larson and Larson (2003) presented a review article of 
longitudinal studies of community samples, which noted that a person’s spiritual 
commitment had a buffering effect on substance abuse. Stewart and Koeske (2005) 
agreed when stating that attendance at religious services serves as a positive indicator of 
non-substance use behavior.  
Stahler et al. (2007) conducted research on 18 homeless, cocaine-using mothers 
who were admitted to a residential treatment program. These African American women 
were randomly assigned to a group receiving either traditional medical treatment or to a 
group receiving traditional medical treatment plus a faith-based element. These women 
were assessed at the time of intake and at 3 and 6 months. The authors reported on the 
effectiveness of faith-based treatment for opiate use among African-American females. 
The authors stated that faith-based treatment produced superior outcomes in retention of 
abstinence after 6 months by 75% versus 20% with non-faith-based and also resulted in 
improved cost effectiveness.  
Duvall, Staton-Tindall, Oser, and Leukefeld (2008) conducted a survey over a 
period of 24 months of 500 Kentucky Drug Court clients. The study noted the perceived 
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addiction severity of the individual and found that clients indicated that faith was 
considered as having a positive impact upon mental health and addiction recovery by 
promoting abstinence through the interaction of like-minded peers. 
 There are no strict or identifiable definitions of what constitutes a faith-based 
program and according to Neff et al. (2006) faith-based programs vary in their format. 
Some faith-based programs may be faith-based in name only and use the concept of faith 
only in the context of attracting clients while other faith-based programs are more 
spiritually focused and incorporate religious resources and material (Mcllwrath, 2011). 
Sider and Unruh (1999) categorize faith-based treatment into four areas:  (a) completely 
religious, (b) religious and secular combined, (c) secular with religious values, or (d) 
religious affiliation only. There are numerous religions and religious based organizations, 
which provide treatment for substances abuse but the Christian faith is most common 
(McCoy, Hermos, Bokhour, & Frayne, 2004). Conducting qualitative interviews, Arnold, 
Avants, Margolin, and Marcotte (2002) noted that patients prefer to include elements of 
FBS in their treatment of substance use. 
Rationale for FBS. The rationale to examine whether faith plays a significant role 
in the treatment of opiate addiction is based on history. Throughout history, faith has 
been an element in the healing process. Ancient healers believed that a pantheon of gods 
was active in all of the affairs of ones’ life and to receive healing, one had to petition the 
gods. This petition process might involve offering a sacrifice or performing a task in 
order to gain the gods attention and benevolence. The misnomer was that all disease and 
illness were the direct results of sin toward God or toward part of His creation (Kroll & 
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Bachrach, 1984). There is believed to be a connection or link existing between faith and 
recovery (King, 1994). There is a spiritual link between the healing power of prayer (faith 
and healing) and the practice of medicine (Dossey, 1993).  The author promoted the idea 
that prayer was a valid and vital tool, comparing it to surgery and medications in the 
recovery process. 
   Hyman and Pedrick (2010) discussed the emphasis of faith in responsibility 
modification therapy (RMT). RMT is an approach where accountability is transferred to 
someone else, even to God or to a higher being. RMT involves giving the responsibility 
for all obsessional fears completely and absolutely to God. Narcotics Anonymous (NA) 
encourages the use of accountability partners and the belief and inspiration found in a 
higher power.  
In recent years, a holistic approach has been associated to healing. Koenig et al. 
(2000) cited 1,200 studies indicating an acceptance of holistic medicine as a treatment 
option with over 66% of the studies reflecting significant associations between (a) faith 
and religious activity and (b) better mental and physical health along with decreased use 
of health care services. Saputo and Faass (2002) agreed when stating their belief that 
“people who have strong faith, religious belief, or a spiritual practice enjoy better 
physical, mental, and emotional health” (p. 1473).  
A poll conducted by McNichol (1996) of 1,000 American adults found that 79% 
believed there was a positive association between spiritual faith and disease recovery. 
Mansfiled et al. (2002) conducted a random-digit-dial telephone survey in 1997 of 1052 
adult households in 41 counties of eastern North Carolina. The survey assessed the 
   
43 
beliefs of the individuals surveyed regarding the importance and effect of faith in healing 
and recovery. The authors analyzed data using descriptive statistics, factor analysis, t-
tests, analysis of variance, and logistic regression. The survey results found that 87.5% 
believed in miracles of healing and linked faith to recovery.  
 Faith and faith-based practices, such as prayer and meditation, are associated 
with improved health and health outcomes after a sickness and longer life expectancy 
(Sinatra, Roberts, & Zucker, 2007). Religion acts as a buffering agent in adolescent 
substance use (Wills, Yaeger, & Sandy, 2003). Alcoholics Anonymous (AA) and 
Narcotics Anonymous (NA) encourage clients to seek faith in a higher power as a part of 
the treatment steps.  
The Drug Abuse Treatment Outcome Studies (DATOS) are the most recent 
national evaluation of treatment for opiate addictions (Flynn et al., 2003). DATOS 
included interviews with 10,010 patients admitted to one of 96 drug treatment programs 
in eleven cities in the United States from 1991 through 1993 and included follow-up for 5 
years. Of the 10,010 interviewed, 708 were chosen for the study. Participants, at intake 
and one week from intake were given a self-reported assessment, which measured drug 
use and illegal activity. Daily drug use and illegal activity was also monitored through 
self-report. Recovery Perception Scales were used by participants to find what they felt 
were reasons for recovery. An ANOVA, analyzing variance was used for testing 
procedures. The authors found that 82% of individuals indicated personal motivation and 
60-63% of individuals listed religion/spirituality as important to recovery.  
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Theoretical Framework 
Maslow  
During his life, Maslow proposed that man could achieve higher states of 
actualization and believed that psychology should focus on individuals as a whole and 
their actions. Man was an integrated being and has similar and shared needs, which were 
hierarchical in nature (Maslow, 1986). He described man as being able to reach a level 
when base needs are set aside for a higher power.  
   Initially, Maslow’s hierarchy of needs (1943) composed a 5-stage model 
including physiological, safety, belonging, self-esteem, and self-actualization. This 
original model has been expanded upon several times throughout the years and now may 
include as many as eight different stages. Maslow proposed that the base needs of the 
individual must be met before any higher level of self –actualization can occur. The 
premise of the base level involves the focus on basic issues and necessities of life. 
Maslow identified the base needs as items such as food and health. Maslow’s model 
listed “considerable ramifications for the treatment of individuals with complex and 
multi-axial problems” (Best et al., 2008, p. 306). This theory considered the interaction of 
multiple need factors upon an individual including social and cultural aspects, 
psychological, physiological, and pharmacological and treatment occurring from a 
holistic concept.  
Integration of religion, science, and social passion is needed for the fulfillment of 
human needs (Maslow, 1970). The individuals’ base physiological needs require attention 
to be met but once these lower needs are met, higher needs such as safety, belonging, 
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esteem, and then self- actualization take precedence and this process is continued 
throughout life in a more fluid process (Best et al. 2008). Maslow stated that basic human 
needs can only be fulfilled by other people (Maslow, 1970).  
Individuals require a context of values and thinking, and that faith is an aspect of 
necessary structure for life (Maslow, 1962). Maslow compared man’s need for faith to 
the natural components of sunlight and calcium. The relationship of body, mind, and 
spirit to addiction and the connection of the motivators for substance use are derived from 
unmet needs (Alexander, Robinshon, & Rainforth, 1994). The reasons for opiate 
addiction are multiple and include physiological, psychological, sociological, and 
spiritual (White, 1998). Tse, Leung, and Ho (2012), in a convenience study of 302 elderly 
nursing home patients, recommended a holistic approach for the effective treatment of 
base psychological needs.  
The implications of this theory when associated with substance use are multiple. 
Many needs may accompany the client who is suffering with substances. The initial 
intake issues associated with substances are many and may include problems of 
homelessness, legal issues, health, relational, and occupational (Best et al., 2008). At the 
base of the pyramid are the immediate physiological needs of medication and integration 
of holistic treatment. Higher up the pyramid the needs of safety, occupational, legal, and 
residential may be addressed. In the outpatient opiate clinic, the addictions client is 
receiving treatment for base needs.  
Faith is an empowering force for ones wellbeing when discussing the application 
of Maslow’s hierarchy of needs to behavioral motivation and change (Brown & Cullen, 
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2006). Brown and Cullen (2006) conducted a study of 125 participants incorporating a 
self-administered questionnaire of 76 statements based upon the main categories of 
Maslow’s hierarchy of needs. The authors studied the effect of faith as a motivational 
element for ones’ self-actualization. Although this study did not incorporate any 
identified substance abuse participants, the authors suggested that faith served as a 
motivational element for change. Faith plays a vital role in reaffirming hope for the future 
and meaning in life (Musick, 2000).  
The hierarchy of needs theory has been applied to a “trans-disciplinary” (Best et 
al., 2008, p. 307) or integrated approach for treatment. Although not specifically tied to 
opiate abuse, Maslow’s hierarchy of needs may be integrated to substance use with 
regard to man’s base physiological needs of medication and integration of holistic 
treatment and may also be applied to higher level needs of self-actualization.  
Theoretical Propositions, Hypotheses and Assumptions 
The first research question for this study is to what extent does type of treatment, 
(MT or FBS) predict compliance as measured by UDSs, after controlling for the control 
variables of dual diagnosis, college education, and income. The second research question 
is to what extent does type of treatment, (MT or FBS) predict compliance as measured by 
kept pill count, after controlling for the control variables of dual diagnosis, college 
education, and income. It is the hypothesis that when receiving treatment for opiate 
addiction, individuals voluntarily participating in FBS in addition to MT will have higher 
compliance outcomes than individuals receiving MT only.  
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There are several assumptions in this study. It is assumed that FBS will 
significantly predict compliance over and above MT due to the emphasis placed on 
holistic measures of treatment and the element of faith. It is also assumed that people 
enrolled in an opiate treatment program are addicted to opiates. It is assumed that 
information regarding the clients’ attendance and compliance was entered into the 
clients’ electronic record accurately. It is also assumed that the client is truthful in 
relating the intake and biopsychosocial information to the social worker. Another 
assumption is that intake data is accurate and that individuals have received a proper 
diagnosis. An assumption of the study is that MT does not include FBS elements in the 
treatment process and that FBS is truly reflective of the stated definition. A final 
assumption is that urine samples provided were unique to the individual client and were 
collected and tested in a precise manner.  
Rationale of Variables  
Mental Illness and Dual Diagnosis  
The National Alliance on Mental Illness (NAMI) described mental illness as a 
medical condition that impedes a person’s ability to function in all life areas and which 
may disrupt the ability to process feelings and emotions and the ability to relate to others. 
NAMI has also stated that 25% of individuals will experience an episode of mental 
illness (NAMI, 2013). Major mental illnesses include: schizophrenia, bipolar disorder, 
anxiety disorders, and major depression. General characteristics of schizophrenia may 
include the presence of auditory, tactile, or visual hallucinations and the presence of 
delusional or paranoid thinking. Bipolar disorder may include the characteristics of 
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persistent mood swings alternating between mania and depression over the course of 
hours, days, or weeks. Anxiety characteristics may include feelings of restlessness, fear, 
or panic. Anxiety disorders are the most common and effect 20% of individuals (NAMI, 
2013) and include post-traumatic stress disorder, obsessive compulsive disorder, and 
panic disorder. Generalized anxiety disorder “accounts for 110 million disability days per 
year” (DSM-5, 2013, p. 225) in the United States. Characteristics of depression include 
intense feelings of sadness and loneliness and may include suicidal ideation. 
The presence of depression increases the risk of substance use (Goodman & 
Huang, 2002). The authors conducted a linear regression analysis of cross-sectional data 
from the National Longitudinal Study of Adolescent Health (1995) of 15,112 students 
and found a link between mental illness and substance use. There is a high prevalence of 
co-existing psychiatric disorders and opiate dependent users (WHO, 2008). Depression is 
present in nearly half of those having an opiate dependence diagnosis (Benyamina et al., 
2011). 
Faith and Dual Diagnosis 
Piacentine (2010) conducted a descriptive and cross sectional correlational design 
in a major Midwestern city of a clinic with 400 clients, 108 participating in the study to 
explore the relationship between spiritual well-being, depression and anxiety, and the 
consequences of continued drug use. Piacentine (2010) used a one-sample t test, 
Pearson’s r, and multiple and logistic regression as testing measures and found a 
correlation between spiritual well-being and decreased feelings of depression, anxiety 
and an adverse finding related to poor spiritual well-being and drug use.  
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 Many times, substance use is accompanied by other precursors of mental illness 
indicating the necessity for a dual diagnosis. Those individuals suffering from a mental 
illness are more likely to have a coexisting substance use problem (Drake et al., 2001) 
and have a higher potential for relapse during treatment (Kola & Kruszynski, 2010). Dual 
diagnosis has been defined by (Patrick, 2003) as a term to denote the presence of a 
mental illness coexisting with an alcohol or drug problem and that the combination of the 
problem is larger than either separately. Hoffman et al. (2003) defined dual diagnosis as a 
deteriorating condition that is both interrelating and chronic.  
Individuals suffering from a mental illness and a substance abuse problem have 
been referred to both types of treatment programs. Barreira (2000) noted that in the past, 
people diagnosed as having both a severe mental illness and a substance abuse problem 
were treated in separate programs, which did not adequately care for their treatment 
needs. Hoffman et al. (2003) concurred when reporting on past treatment for the dually 
diagnosed client related that historically the client has been treated in parallel programs, 
which were separate in nature and produced poor compliance and continued relapse.  
The inclusion of dual diagnosis as a control variable for this study is based on a 
study conducted by Pardini et al. (2000) of 236 individuals living in one county in 
California who were recovering from substance abuse. The authors examined the 
relationship between religious faith, spirituality, and positive mental health outcomes. A 
non-denominational religious faith measure was used to measure core behaviors and 
beliefs pertaining to items such as prayer, belief in a God, or sense of a guiding faith. The 
researchers used an anxiety scale and a ten point Likert scale addressing the individuals’ 
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perception of religious faith, the element of faith was shown to be instrumental in the 
treatment of opiates and mental illness. The researchers allowed participants to respond 
to self-answer questionnaires. Strong levels of faith help to build and support positive 
mental and physical health (Pardini et al., 2000).  
Rationale for an Integrated Approach in Dual Diagnosis  
Prior to the use of an integrated treatment for addictions and mental illness, clients 
were treated either in an addictions or a mental health clinical setting with programs 
which were specific to their needs or possibly missing out on needed services altogether 
(Osher & Drake, 2010). The argument of which service was to be implemented first 
usually included some advocating for the necessity of the addiction being treated first in 
order to determine if a mental illness exists, while others were advocating for the 
treatment of the mental illness first with the explanation that the client may have been 
self-managing symptoms. During the 1990s, the focus of treatment began to change. 
Ackerson (1995) was an early advocate who examined the use of an integrated approach 
in dual diagnosis using what was called Continuous Treatment Teams. 
College Education  
 The rationale for including college education as a control variable in this study is 
based on a study by Bryant, Schulenberg, O’Malley, Bachman, and Johnston (2003). The 
authors conducted a six year longitudinal study and found that educational achievement 
among high school students was linked to the percentage risk of substance use. Johnston, 
O’Malley, Bachman, and Schulenberg (2010), backed by the University of Michigan’s 
Institute for Social Research and under the direction of the National Institute on Drug 
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Abuse, over a period of 35 years conducted surveys assessing drug use and an 
individual’s level of education and found significant decreases in substance use when 
associated with a higher level of education. This study found that heroin use declined 
while substances such as oxycodone remained virtually unchanged.  
Dos Santos, Trautmann, and Kools (2011) used a rapid assessment and response 
semi-structured interview of 84 informants found that living in abject poverty, with 
limited resources for living and education served as complications to opiate treatment. 
The authors did not present clear, exact or precise answers regarding what constituted 
poverty or limited resources. No specific findings were presented in this study.  
Substance abuse, including alcohol and marijuana, impacts academic 
performance. Several previous studies have been conducted regarding the effect of 
alcohol use and education (Cook & Moore, 1993; Koch & Ribar, 2001). Bray, Zarkin, 
Ringwalt, and Junfeng (2000) using data from a school system in the Southeastern United 
States on 1,392 students found a connection between marijuana use and poor academic 
performance and dropout.  
Income 
 The rationale for including income as a control variable was based on several 
studies. One of these studies was conducted by Goodman and Huang (2002), which 
found a link between higher socioeconomic status and decreased substance use. The 
prevalence of substance use rose with the variables of unemployment but decreased 
dramatically among college graduates and professionals (Merline, O’Malley, 
Schulenberg, Bachman, & Johnston, 2004). The authors used data obtained from 
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Monitoring the Future, a national sample of 17,000 high school seniors, with a weighted 
sample of 7,541. Students were grouped according to the year of their graduation and 
then were categorized into one of five categories based upon their response to which 
category best described their job. Students were also grouped according to marriage 
status, employment, and substance use.  
Religious participation may impact substance use in low-income families. Hill 
and McCullough (2008) conducted a probability study of 2,402 low-income single 
mothers from Boston, Chicago, and San Antonio using data from the Welfare, Children 
and Families project over a two-year period. The authors used an ordered logistic 
regression formula and found that higher religious participation is associated to lower 
intoxication among low-income single female parent families.  
SAMHSA (2012) in 2011 found that 14.8% of United States adults had a 
substance abuse or dependence diagnosis and were unemployed. This compared to 8.4% 
who had a substance abuse or dependence diagnosis and were employed. Gascon and 
Spiller (2009) used the data from the United States Census Bureau and the Department of 
Labor, and viewed the unemployment rate and opiate use in Kentucky during the time 
period of 2000-2005 and found a correlation between higher opiate use and higher 
unemployment.  
Summary  
 The purpose of this study was to determine which treatment approach—MT or 
FBS—produces better compliance among patients attending an opiate outpatient 
treatment center in Appalachia and to what extent do the variables of dual diagnosis, 
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income, and college education predict compliance. It was the hypotheses that when 
receiving treatment for opiate addiction, individuals voluntarily participating in FBS in 
addition to MT will have higher compliance outcomes than individuals receiving MT 
only. This chapter comprised the literature review and viewed the rationale applied when 
discussing the effectiveness of treatment when incorporating a faith-based regimen. This 
chapter also reviewed the theoretical foundations of MT and FBS, Maslows’ hierarchy of 
needs, and IDDT.  Types of medication treatment including methadone, Suboxone, 
buprenorphine, and naltrexone were reviewed for their effectiveness in the treatment of 
opiates. Previous studies have been conducted researching the outcomes of substance use 
treatment. Literature supports the premise that faith-based treatment when added to MT is 
more effective than MT alone but a gap exists in the literature to document the higher 
compliance rate among participants in treatment for opiates treated with a Suboxone 
regimen. According to Piacentine (2009), limited research has been conducted on opiate 
use and faith or in the predictability for recovery.  
Chapter 3 will view the research design, methods of participant recruitment, 
criteria for recruitment, ethical procedures, data collection and analysis for conducting a 
comparative study to identify compliance among two treatment types within an outpatient 
Suboxone treatment center.  
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Chapter 3: Research Method  
Introduction 
This chapter will review the research design, methods of participant recruitment, 
criteria for recruitment, ethical procedures used to safeguard all participants’ rights, data 
collection procedures, analysis, and my role as the researcher. This study will identify 
which of two treatment approaches predicts compliance after controlling for the variables 
of dual diagnosis, income, and education among individuals attending an opiate 
outpatient treatment center.  
The purpose of this study was to determine which treatment approach—MT or 
FBS—produces better compliance among patients attending an opiate outpatient 
treatment center in Appalachia and to what extent do the variables of dual diagnosis, 
income, and college education predict compliance.  
Research Design and Analysis  
This quantitative study of compliance used secondary data obtained from a 
previous 1-year period and used multiple regression to predict compliance based on 
receiving medical treatment (MT) only or medical treatment with  faith-based services 
(FBS) at the Eastern Appalachian Suboxone Treatment Center (EASTC).  Data included 
attendance logs for group therapy, number of clean UDSs, and number of kept pill count 
and was obtained through use of depersonalized electronic records. A stepwise linear 
regression analyses was chosen to test the hypotheses associated with both research 
questions, to what extent does type of treatment (MT or FBS) predict compliance, as 
measured by clean UDS (RQ1) or pill count (RQ2), over and above dual diagnosis, 
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college education, and income.  Stepwise regression is used to identify the variable with 
the strongest relationship to the dependent variable (Field, 2009).  I had considered 
conducting logistic regression but declined this approach due to the DVs (UDSs and kept 
pill count) not being qualitative and could not be answered through the use of coding 0/1.    
Statistical data, including the presence (yes/no) of a dual diagnosis, the reported annual  
household income, and the presence (yes/no) of college education was also obtained 
using electronic data from the client’s record collected at the time of the client’s initial 
entry into the treatment program. Urine drug screen (UDSs) and pill kept appointments 
was obtained from EASTC archived electronic records. Group attendance in the MT or 
FBS program was measured through the actual number of days attending.  I downloaded 
depersonalized electronic data from clients’ record at the facility while being monitored 
by the EASTC administrator. I recorded data using an index card for each entry. The  
index card, designated as the data collection tool (Appendix B), including a no/yes 
response for dual diagnosis, college education, and FBS. The index card also had three 
lines to record the actual amount of income, the actual number of clean UDSs, and the 
actual number of kept pill count. One other line located in the upper right had corner was 
used to place a checkmark once the data collection tool was recorded in SPSS. I used 
multiple regression in IBM SPSS 21 to predict compliance measured by kept pill count 
and by number of clean UDSs based on type of treatment after controlling for dual 
diagnosis, income, and college education.  
The total available sample size was 103 clients. I used all 103 of the clients and 
then calculated the power using G*Power 3.1.2 analysis software (Faul & Erdfelder, 
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2009). I chose a medium effect size of f2 = .15 since I was unable to find any data to 
support the existence of a smaller meaningful effect. The level of significance was .05. 
With one primary predictor (type of treatment) and three control variables (dual 
diagnosis, income, and college education), statistical power was .97. 
Setting and Recruitment of Participants 
EASTC is a private, for profit Suboxone treatment center located in the tristate 
area of Eastern Kentucky, Southern Ohio, and Western West Virginia, having a capacity 
of 100 clients and focusing on serving the needs of the opiate addicted client through the 
use of medical treatment (MT). The EASTC also offers optional FBS group counseling in 
lieu of MT. The EASTC employing one psychiatrist, a licensed clinical social worker, an 
independent laboratory provider, and two support staff and utilizing a 24-hour support 
hotline. Generalizability of the study may be affected in that the clients seen at EASTC 
are self-pay.  
Data for this study were obtained from a private archival database. Participants in 
this study were voluntary, self-referred, self-pay consumers. The intervention was 
Suboxone with ancillary follow-up including group counseling (either MT or FBS), pill 
count, and urine drug screening (UDSs). Participants were required to complete a 
comprehensive biopsychosocial intake assessment upon entry into treatment; baseline 
UDSs and data was entered into their individual electronic record using TheraScribe. 
Participants could either self-assign to the MT or FBS group sessions at the time of intake 
based upon their preference.  Participants were mandated to attend two sessions per 
month in addition to follow-up with the staff psychiatrist for medication.  
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Research Questions and Hypothesis 
This study was guided by the following research questions: 
RQ1: To what extent does type of treatment (MT or FBS) predict compliance, as 
measured by clean UDSs, over and above dual diagnosis, college education, and income?  
H0
1 = null hypothesis is R2change for Type of Treatment = 0. 
HA
1 = alternative hypothesis is R2change for Type of Treatment > 0. 
RQ2: To what extent does type of treatment (MT or FBS) predict compliance, as 
measured by kept pill count over and above dual diagnosis, college education, and 
income? 
H0
2= null hypothesis is R2change for Type of Treatment = 0.  
HA
2 = alternative hypothesis is R2change for Type of Treatment > 0. 
Permission to conduct the study was obtained from the on-site director at EASTC 
and the Walden University Institutional Review Board Approval # 10-06-14-0187970. 
The study complied with Walden University practices and policies. A certificate of 
completion from the NIH Office of Extramural Research for the protection of research 
participants was obtained. A Confidentiality Agreement (Appendix A) was included.   A 
Letter of Cooperation between Walden University and the EASTC (was not included in 
the Appendix in order to ensure confidentiality) but was obtained prior to conducting this 
study.  
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Variables 
Dependent Variables 
           UDSs was one dependent variable and was the actual recorded number (raw 
count) of clean urine screens found in the record. The second dependent variable was the 
number (raw count) of kept pill count found in the record. 
Independent Variable 
           The independent variable is type of treatment, which has two values. The first 
value is Medical Treatment (MT) and is coded as 0. The second value is faith-based 
Services (FBS) and is coded as 1.  
Control Variables 
Control variables (CV) used for this study included dual diagnosis, income, and 
college education. I computed Spearman’s rho correlation coefficients between each 
control variable and the dependent variables of UDSs and kept pill count. Those variables 
correlated at p = .25 were retained as control variables in the regression analyses. Dual 
diagnosis was coded as 0/1 for absence or presence of dual diagnosis, income as the 
reported annual household income, and college education as the absence/presence of 
college and coded as 0 no college or 1 for college.  
Dual diagnosis includes a diagnosis of mental illness and a diagnosis of substance 
use (Weiss, 2004). Dual diagnosis was measured through the diagnosis obtained from the 
psychiatrist’s intake note recorded in electronic record. College education was measured 
through the use of clients’ electronic record containing biopsychosocial history obtained 
at intake by the social worker and indicating the total number of years the client has spent 
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in obtaining an education. Income was measured by report of the client taken from 
clients’ electronic record containing biopsychsocial history obtained at intake by the 
social worker.  
Participation in MT was coded as 0 and participation in FBS was coded as 1. 
During the intake, clients were asked to describe their religious preference or affiliation 
and to note their level of participation in religious activities.  
Data Collection 
Although EASTC also serves the mentally ill population, a medical diagnosis of 
opiate abuse or dependence as defined by the DSM-IV-TR must be the primary diagnosis. 
The DSM-IV-TR was used due to the data originating prior to DSM-5 publication and 
implementation. No participants were recruited for this study as information was obtained 
through use of depersonalized data thereby insuring and maintaining privacy and 
confidentiality.  
Data were collected by the treatment center at the time of entry into the program 
when the social worker collected biopsychosocial information including the presence or 
absence of opiate abuse or dependence, annual income, absence or presence of college 
education, and preference or no preference for participation in FBS. The presence or 
absence of a dual diagnosis was recorded in the clients’ electronic record by the 
psychiatrist. Information was recorded electronically using TheraScribe. Computer access 
was password protected and backed up on an independent, redundant drive on a weekly 
basis.   
   
60 
Ethical Protection of Participants 
Data was obtained from depersonalized, non-specific records of EASTC clients 
who were self-referred and were voluntarily enrolled in treatment services. Data 
originated from the electronic intake information obtained at time of clients’ entry into 
treatment and kept in electronic records at EASTC. Data indicating compliance through 
attendance to group sessions, and through number of clean UDSs and number of kept pill 
count. This study did not directly involve interaction with any human subjects, and any 
potentially identifying information was depersonalized, thus insuring the protection of 
ethical standards. EASTC does not have any established research protocols.  
Permission was obtained through the submission of a proposal of ethical review 
describing the study and procedures involved. A summary letter and PowerPoint 
presentation will be provided to the director of the EASTC following completion of the 
dissertation. Documentation data pertaining to this study will be maintained for the 
required five year time period and will be stored in a fireproof safe. 
Summary 
This chapter focused on the research design, methods of participant recruitment, 
criteria for inclusion of data in the study, ethical procedures used to safeguard all 
participants’ rights, data collection procedures, and the role of the researcher. This 
involved a quantitative, stepwise multiple regression study viewing the compliance rate 
of patients enrolled in a private, for profit, outpatient Suboxone treatment setting at 
EASTC and explored any differences based on their participation in either a MT or FBS 
approach.  Data included attendance logs for group therapy, number of clean UDSs, and 
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number of kept pill count. The research question asked to what extent does type of 
treatment (MT or FBS) predict compliance, as measured by clean UDS (RQ1) or pill 
count (RQ2), over and above dual diagnosis, college education, and income.  Chapter 4 
presents the results of the analyses. 
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Chapter 4: Data Collection and Results  
Introduction 
This chapter will review the research design and analysis, research questions, 
hypothesis, data collection and statistical procedural results, The purpose of this study 
was to determine which treatment approach—MT or FBS—produces better compliance 
among patients attending an opiate outpatient treatment center in Appalachia and to what 
extent do the variables of dual diagnosis, income, and college education predict 
compliance.  
Review of the Research Design and Analysis  
This study was guided by the following research questions regarding the type of 
treatment and compliance: 
RQ1: To what extent does type of treatment (MT or FBS) predict compliance, as 
measured by clean UDSs, over and above dual diagnosis, college education, and income?  
H0
1 = null hypothesis is R2change for Type of Treatment = 0. 
HA
1 = alternative hypothesis is R2change for Type of Treatment > 0. 
RQ2: To what extent does type of treatment (MT or FBS) predict compliance, as 
measured by kept pill count over and above dual diagnosis, college education, and 
income? 
H0
2= null hypothesis is R2change for Type of Treatment = 0.  
HA
2 = alternative hypothesis is R2change for Type of Treatment > 0. 
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  It is the hypothesis that when receiving treatment for opiate addiction, individuals 
voluntarily participating in FBS in addition to MT will have higher compliance outcomes 
than individuals receiving MT only. 
 This quantitative study of compliance used secondary electronic data, obtained 
from a previous 1-year period, to predict compliance between medical treatment (MT) 
and faith-based services (FBS). These data included attendance logs for group therapy, 
number of clean UDSs, and the number of kept pill/ count. Statistical data included the 
presence (no/yes) of a dual diagnosis, the reported annual household income, college 
education (no/yes), number of clean urine drug screens (UDSs), and the number of kept 
pill/ count. MT was coded as 0 and FBS was coded as 1 in the independent variable type 
of treatment. Fifty-seven clients participated in the MT group and 46 participated in the 
FBS group. Dual diagnosis was coded as 0 for no dual diagnosis and 1 for dual diagnosis. 
There were 49 clients diagnosed with a dual diagnosis. Education was coded as 0 for no 
college education or 1 for college education. There were 27 clients who had attended 
college. The total available sample size was 103 (n=103). UDSs was one dependent 
variable and was measured by the number of clean urine screens in the record and the 
other dependent variable was measured by the number of kept pill count. See Table 1 for 
descriptive statistics for these variables. 
 
 
   
64 
Table 1 
Descriptive Statistics for All Variables 
 Mean Std. Deviation N 
No. of kept pill count  
No. of clean UDSs 
9.93 
14.26 
1.962 
4.415 
103 
103 
Dual diagnosis (Y/N) .49 .502 103 
Income 40873.79 20974.625 103 
College (Y/N) .27 .447 103 
Type of treatment 1.35 .479 103 
    
 Table 2 shows the results of the Spearman’s rho with clean UDSs and kept pill 
count as the dependent variable.  
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Table 2 
Spearman’s rho Using UDSs and Kept Pill Count as Dependent Variables 
 
      
 
No. of 
clean UDSs 
No. of kept 
pill count 
Dual diagnosis 
(Y/N) 
College 
(Y/N) 
Income Type of 
treatment 
Spearman's 
rho 
No. of clean 
UDSs 
Correlation 
Coefficient 
1.000 .616** .133 .096 .275** .054 
Sig. (2-tailed) . .000 .182 .333 .005 .586 
N 103 103 103 103 103 103 
No. of kept 
pill count 
Correlation 
Coefficient 
.616** 1.000 .049 .095 .111 .124 
Sig. (2-tailed) .000 . .622 .340 .264 .211 
N 103 103 103 103 103 103 
Dual diagnosis 
(Y/N) 
Correlation 
Coefficient 
.133 .049 1.000 .323** -.071 .225* 
Sig. (2-tailed) .182 .622 . .001 .476 .022 
N 103 103 103 103 103 103 
College (Y/N) 
Correlation 
Coefficient 
.096 .095 .323** 1.000 .344** .056 
Sig. (2-tailed) .333 .340 .001 . .000 .577 
N 103 103 103 103 103 103 
Income 
Correlation 
Coefficient 
.275** .111 -.071 .344** 1.000 .297** 
Sig. (2-tailed) .005 .264 .476 .000 . .002 
N 103 103 103 103 103 103 
Type of 
treatment 
Correlation 
Coefficient 
.054 .124 .225* .056 .297** 1.000 
Sig. (2-tailed) .586 .211 .022 .577 .002 . 
N 103 103 103 103 103 103 
** Correlation is significant at the 0.01 level (2-tailed). 
* Correlation is significant at the 0.05 level (2-tailed). 
 
 I intended to conduct stepwise linear regression analyses to test the hypotheses 
associated with both research questions by first entering all three control variables dual 
diagnosis, income, and education into the equation on step 1 and then entering type of 
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treatment at step 2. However, after computing Spearman rho coefficients between each 
control variable with each dependent variable I eliminated any control variables that did 
were not significantly correlated at p = .25 from the stepwise analyses. As a result, when 
UDSs was the dependent variable, dual diagnosis and income were retained as control 
variables and no control variables were retained when kept pill count was the dependent 
variable (see Table 2). 
I chose to conduct a Spearman’s rho due to the lack of normal distributions of the 
variables of dual diagnosis, income, and college education. Field (2009) stated that 
Spearman’s rho is used when “data have violated parametric assumptions such as non-
normally distributed data (p. 179).  
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 Table 3 shows the model summary for the variables of income, dual diagnosis, 
and type of treatment and the Adjusted R square.  
Table 3 
RQ1 Model Summary for clean UDSs 
________________________________________________________________________ 
Model R R 
Square 
Adjusted R 
Square 
Std. Error of 
the Estimate 
Change Statistics 
R Square 
Change 
F 
Change 
df1 df2 Sig. F 
Change 
1 .263a .069 .031 4.345 .069 1.826 4 98 .130 
2 .257b .066 .038 4.330 -.003 .339 1 98 .561 
3 .246c .060 .042 4.322 -.006 .601 1 99 .440 
4 .230d .053 .044 4.317 -.007 .789 1 100 .376 
a Predictors: (Constant), Type of treatment, College (Y/N), Dual diagnosis (Y/N), 
Income 
b Predictors: (Constant), Type of treatment, Dual diagnosis (Y/N), Income 
c Predictors: (Constant), Dual diagnosis (Y/N), Income 
d Predictors: (Constant), Income 
e Dependent Variable: No. of clean UDSs 
 
As shown in Table 3, income explains about 5% of the variance (R2 = .053) in 
number of clean UDSs but is not significant at p = .376;  adding dual diagnosis to the 
equation increases R2 to .060 but is not significant at p = .440; adding type of treatment  
also increases the R2  to .066 but also increases non-significance to .561. Therefore the 
null hypothesis that type of treatment predicts number of clean UDSs is not rejected.  
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Figure 1 Normal P-plot of Regression Standardized Residual DV: No. Clean UDS. 
 
 Figure 1 shows the residuals are normally distributed by use of p-plot. 
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Figure 2.  Histogram DV: Clean UDS. 
 Figure 2 shows the histogram for regression of residuals with the dependent 
variable of clean UDSs.  
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 Table 4 shows the unstandardized and standardized coefficients for RQ1 that were 
used to calculate the predicted number of clean UDSs, the differences between predicted 
values and the actual values for each subject (i.e., the residuals).  
Table 4 
Coefficients for RQ1 
________________________________________________________________________ 
Model Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 95.0% Confidence 
Interval for B 
B Std. 
Error 
Beta Lower 
Bound 
Upper 
Bound 
1 
(Constant) 12.281 .935  13.130 .000 10.425 14.136 
Income 
4.848E-
005 
.000 .230 2.379 .019 .000 .000 
2 
(Constant) 12.837 1.368  9.385 .000 10.123 15.551 
Income 
5.228E-
005 
.000 .248 2.426 .017 .000 .000 
Type of 
treatment 
-.527 .943 -.057 -.559 .577 -2.399 1.344 
a. Dependent Variable: No. of clean UDSs 
 
 
Research Question 2: Kept Pill Count as a Dependent Variable 
 Based on Table 3, none of the control variables were significant at or below p = 
.25; therefore, I only ran the regression with type of treatment as the predictor of number 
of kept pill count.  
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 Table 5 shows the Model Summary for RQ2 which indicates failure to reject the 
null hypotheses with respect to type of treatment predicting kept pill count data.  
Table 5 
RQ2 Model Summary   
________________________________________________________________________  
Model R R 
Square 
Adjusted R 
Square 
Std. Error of 
the Estimate 
Change Statistics 
R Square 
Change 
F 
Change 
df1 df2 Sig. F 
Change 
1 .078a .006 -.004 1.965 .006 .613 1 101 .435 
a. Predictors: (Constant), Type of treatment 
b. Dependent Variable: No. of kept pill counts 
 
Table 5 addresses the variance (R2 = .006) of Type of Treatment but is not 
significant at p = .435. Therefore the null hypothesis that type of treatment predicts 
number of kept pill count is not rejected.  
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Figure 3. Histogram: DV Kept Pill Count 
 Figure 3, the Histogram shows that residuals are close to normal and regression is 
robust with respect to that assumption.  
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Figure 4. Normal P-Plot of Regression Standardized Residual DV: Kept Pill Count. 
 
 Figure 4 shows the p-plot for the dependent variable of number of pill/strip count.  
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Table 6 shows the regression coefficients for RQ2 that were used to calculate the 
predicted number of kept pill count and the differences between the predicted values and 
the actual values for each subject (i.e., the residuals).  
Table 6 
Coefficients for RQ2 
Model 
 
 
 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. Correlations Collinearity 
Statistics 
B Std. 
Error 
Beta Zero-
order 
Partial Part Tolerance VIF 
1 
(Constant) 9.503 .581  16.347 .000      
Type of 
treatment 
.318 .406 .078 .783 .435 .078 .078 .078 1.000 1.00
0 
a. Dependent Variable: No. of kept pill count 
Type of treatment was not found to be significant to compliance.   
  
Summary 
 This chapter focused on the data collection and statistical test results. A 
Spearman’s rho was conducted. Dual diagnosis was not significant to clean UDSs or to 
kept pill count and college education was not significant to clean UDSs or to kept pill 
count. Multiple stepwise linear regression was used to answer RQ 1 and RQ2. The data 
found that income explains about 5% of the variance of clean UDSs with a significant f 
change of .019 while the type of treatment was not close to significance.  I must fail to 
reject the Null Hypothesis and must conclude that the type of treatment does not 
significantly impact clean UDSs. Chapter 5 will examine the findings and limitations of 
this study and implications for social change.   
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Chapter 5: Findings 
Introduction  
The purpose of this study was to determine which treatment approach—MT or 
FBS—produces better compliance among patients attending an opiate outpatient 
treatment center in Appalachia and to what extent do the variables of dual diagnosis, 
income, and college education predict compliance.  
This quantitative study sought to measure the compliance of individuals enrolled 
in an outpatient Suboxone treatment center located in the Appalachian tristate area, who 
voluntarily participated in either a MT or MT that incorporated a FBS. Compliance was 
measured using multiple regression on electronic secondary data obtained from the 
facility. The secondary data described the number of clean urine drug screens (UDSs), 
group sessions attended, and the number of kept pill/strip counts.  
 The control variables were dual diagnosis, college education, and income. Dual 
diagnosis and education were found not to be statistically significant with respect to clean 
UDSs. Dual diagnosis, income, and college education were not found to be statistically 
significant with respect to compliance when measured by the kept pill count. RQ1 asked: 
To what extent does type of treatment (MT or FBS) predict compliance, as measured by 
clean UDSs, over and above dual diagnosis, college education, and income? The data 
showed that income explains about 5% of the variance of clean UDSs while the type of 
treatment was not statistically significant. Based on these results, I reject the null 
hypothesis. Based on these research reviews, the type of treatment (MT or FBS) does not 
significantly impact treatment compliance when using clean UDSs as the measure. RQ2 
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asked: To what extent does type of treatment (MT or FBS) predict compliance, as 
measured by clean UDSs, over and above dual diagnosis, college education, and income? 
The data showed that dual diagnosis, income, or college education were not significant 
factors impacting treatment compliance when using kept pill count as the indicator. Type 
of treatment, FBS or MT did not significantly impact client compliance with treatment 
when using kept pill count as the measure.  
Interpretation of the Findings 
Individuals with an opiate addiction have a higher rate of noncompliance with 
prescribed treatment and that noncompliance limits treatment effectiveness and may 
increase the burden of care and cost for society (Weiss, 2004). Effective opioid treatment 
would decrease relapse, decrease the incidence of communicable diseases, hospital 
emergency room incidents and overdoses (Smith-Rohrberg et al., 2004). Appalachia, 
including the tristate area of Kentucky, West Virginia, and Ohio, has been dramatically 
impacted with increased arrests and death associated with opiate addiction (Cicero et al., 
2005, Havens et al., 2007; Zhang et al., 2008).  
 Approximately 50% of individuals diagnosed with a chronic and severe mental 
illness also have a coexisting diagnosis of substance use (Drake et al., 2001; Kola & 
Kruszynski, 2010). The importance of an integrated treatment approach in the treatment 
of mental illness and addiction use was advocated by Grella et al. (2004). As shown in 
Table 1, dual diagnosis was prevalent in 49% of the cases which was consistent with 
these statements. However, dual diagnosis was not statistically significant with regard to 
compliance as measured by either the clean UDSs or kept pill count measures. 
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  Treatment for dual diagnosis should be simultaneous and carefully synchronized 
to be effective (Lehman et al., 1989; Minkoff, 1989; Osher & kofoed, 1989). Effective 
treatment of dual diagnosis includes integration of substance use and mental health 
treatments (The National Institute of Mental Health, 1989; Teague et al., 1990). In this 
study, both the MT and FBS have a component of integration. Both the MT and FBS 
integrate medication management, UDSs, and group psychotherapy. FBS differs in the 
additional services received. 
A faith-based recovery model for substance use treatment provides greater 
support and social strengthening for the individual (Moos, 2006). This area of Appalachia 
has a rich culture based on tradition, family, pride, and religion (ARC, 2010) and a faith-
based ideology is important to the effectiveness of substance use treatment (Miller, 
2000). Body, mind, and spirit are intertwined and each requires integrated care (O’Brien, 
2013). 
 FBS offers important structured programs in the treatment of substance use 
(White, 1998). The data from this study showed that the type of treatment in which a 
client participated was not significant to compliance as measured by clean UDSs and that 
FBS did not lead to higher compliance. In this area the research results differed from the 
other studies. 
 Faith-based care confirms a person’s sense of self-worth, helps to define a 
meaning and purpose for life, and helps to perpetuate emphatic feelings for others 
(Greasley et al., 2001). Increased faith-based involvement was positively linked to lower 
substance use and less symptoms of depression among adults (Moreira-Almeida et al., 
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2006). This study was quantitative in nature, using attendance data obtained from a 
previous year and did not explore qualitative measures.  
FBS involvement served as a safeguard against substance abuse and aids in 
achieving and maintaining continued sobriety (Stahler et al., 2007). Organizations 
incorporating a faith-based element to addiction treatment serve as protective elements 
when associated with alcohol and drug abuse (Ferguson et al., 2006). Attendance at 
religious services serves as a positive indicator of non-substance use behavior (Stewart & 
Koeske, 2005). Involvement in a faith-based program has been shown to be effective for 
decreasing drug use (Gartner et al., 1991; Gorsuch, 1995; Kendler et al., 2003; Koenig, 
2001; Piacentine, 2010; Richard et al., 2000; Wills et al., 2003). The effectiveness of 
religious programs versus secular programs of treatment to substance abuse was noted by 
Hood (2011). Columbia University’s National Center on Addictions and Substance 
Abuse (CASA, 2001) related the individual indicating a presence of faith in their lives 
had a lower percentage of substance use.  A person’s spiritual commitment had a 
buffering effect on substance abuse (Larson & Larons).  Faith-based treatment produced 
superior outcomes in retention of abstinence after 6 months by 75% versus 20% with 
non- faith-based and also resulted in improved cost effectiveness (Stahler et al., 2007). 
Faith was considered as having a positive impact upon mental health and addiction 
recovery by promoting abstinence through the interaction of like- minded peers (Duvall 
et al., 2008). The results of this study did not find statistical significance in the FBS 
treatment program verses the MT. It appears both programs were equally successful with 
no differences in compliance. Adding the FBS component did not add anything to the 
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MT alone based on these dependent variables. The results of this study do not support 
that the type of treatment predicts compliance, as measured by UDSs, over and above 
dual diagnosis, college education, and income.  
Limitations of the Study 
This study had several limitations. The first limitation was the size of the study 
group which was limited due to the regulations on the number of Suboxone treatment 
clients allowed in the center. This study was also limited to the recorded data obtained 
from a Suboxone treatment center located in Eastern Kentucky and serving clients from 
the Appalachian areas of Eastern Kentucky, Southern Ohio, and Western West Virginia. 
This study may have a unique population and geographical composition and may not be 
generalizable beyond this specific population due to limited cultural diversity. 
Appalachia may be known for its production of coal, poor economy, high poverty rate 
(Hall et al. 2008), high unemployment (Bureau of Labor Statistics/US Department of 
Labor, 2013), poor educational system, poor health and higher fatality levels from drug 
overdose (Hall et al., 2008) but is also known to have a rich culture that is deeply focused 
on traditions, history, and relationships (ARC, 2010) with its values focused on family, 
religion, pride, independence, hospitality, modesty, beauty, patriotism, love of home, 
individualism, and humor (Jones,1974). The cultural pride and independence of 
Appalachia is described as a type of cultural isolation (Christian et al., 2010) which might 
also make this study not generalizable beyond this geographic region. There might be 
cultural or geographical factors, which may have led to the differences between the 
results found and the other published studies. This would require future study. 
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Another limitation was the use of electronic archival data within the facility. Data 
was obtained through on-site records review of compliance rates from a previous one 
year course of treatment collected and depersonalized by the researcher and monitored by 
the EASTC administrator. This might be a limitation based on the assumption that data 
was collected and recorded at the EASTC center correctly and without bias.  
Recommendations for Action 
 Even though this study did not identify any aspects of faith significantly 
influencing compliance, and both MT and FBS showed similar results, the way that 
progress is personally perceived by the individual may impact treatment compliance. It is 
not known if personal preference and the level of change and perceived support varies 
from individual to individual. It is also unknown if people engaged in FBS may feel as if 
they have experienced a different experience and relate this to their concept of faith and 
compliance. As quantitative research generally concentrates on breadth and qualitative 
research focuses on depth and meaning, future recommendations include a mixed 
methods design allowing for a study conducting survey, interviews, or in-depth case 
studies and including the quantitative predictors of attendance and interaction. 
Recommendations for Research 
 This study showed that the type of treatment in which one enrolls for opiate 
treatment with Suboxone did not significantly impact compliance in the tristate area of 
Appalachia as measured by clean UDSs or kept pill count. It may still be debatable, that a 
clients’ perception of faith impacts their personal compliance and ultimate success in 
treatment for opiate use. It is unknown if an issue of selection preference (MT or FBS) 
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may initially motivate a client to attend Suboxone treatment. A further future study may 
also be conducted assessing the role of interaction and attendance to compliance, 
measured through clean UDSs and kept pill count. This study used an electronic data set; 
a future study may be implemented involving direct testing of human subject responses. 
This study focused on the Appalachian tristate area of Kentucky, Ohio, and West 
Virginia. Future studies may be implemented serving a larger or more divergent and 
culturally diverse population of Appalachia. 
Implications for Positive Social Change 
 Opioid use is not a new issue but is an issue that continues to impact the United 
States (DeQuency, 1998; Compton & Volkow, 2005; Weiss et al., 2010) medically (Day 
et al.; DAWN, 2009; Gardner & Kosten, 2007; Morgan & Crane, 2010; SAMHSA, 
2003b; WHO, 2008), financially (Morgan & Crane 2010), through criminal activity and 
legal intervention (Davis et al., 2006; Mays et al., 2005; Birnbaum et al,. 2011), and 
impacts families (Day et al., 2008) while few attend or participate in treatment programs 
(McCance-Katz, 2004). The National Institutes of Health (2013) reported that for every 
$1 spent on medication assisted treatment for drug addiction saves society between $2 
and $6 dollars.  
 Individuals participating in a medical treatment program and a 12-step program 
had a decreased rate of use than those who only participated in either the medical 
treatment program or the 12-step program (Fiorentine & Hillhouse, 2006). Weis et al. 
(2005) conducting a study of 487 cocaine-dependent individuals undergoing a 24-week 
outpatient randomized controlled trial for behavioral treatment taken from five different 
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sites using a 12- step program measuring both attendance and participation found that 
active participation in a 12-step program for a period of 1 month showed a decreased 
amount of cocaine use in the next month. Also found was that those patients who 
increased their 12-step participation initially, during the first 3 months of treatment, 
showed a significant decrease in cocaine use for the next 3 months. Increased 
participation and involvement in support groups leads to enhanced effective treatment for 
substance use (Gossop & Marsden, 2008).  
 The determination of effective treatment options for opiate addiction treatment 
and increased compliance may help reduce the negative impact on individuals through 
increasing life expectancy (Carter et al., 2012), and improved physical health through 
decreasing the number of self-harm injuries (Fornili & Alemi, 2007). Effective treatment 
options for opiate addiction treatment and increased compliance may also help decrease 
adverse effects on family members, co-workers, and other members of society by 
decreasing relapse, communicable disease, hospital emergency room visits, and 
overdoses (Smith-Rohrberg et al., 2004) and may decrease the financial burden of care on 
society which Ruetsch (2010) states costs almost half a trillion dollars in costs associated 
with medical, economic social, and judicial/legal expenses due to substance use. Based 
upon the results of this study, with both MT and FBS being so similar in their 
relationship to compliance, implications suggest that attendance and participation in 
treatment may be future areas for study. 
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Conclusion 
This study sought to measure the compliance of individuals voluntarily enrolled in 
an outpatient setting in the tristate area of Kentucky, Ohio, and West Virginia who 
participated in either a medical treatment (MT) or MT incorporating a faith-based 
component of service (FBS) for the treatment of opioid addiction and incorporated a 
secondary electronic data analysis using multiple regression. Analyses of data showed 
that both programs were equally successful with no differences in compliance, adding the 
FBS component did not add anything to the MT alone based on these dependent 
variables. The results of this study do not support that the type of treatment predicts 
compliance, as measured by UDSs or by kept pill count, over and above dual diagnosis, 
college education, and income.  
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